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Abstract

The United States Air Force has high volume biological air sampling equipment available
including the XMX/2L-MIL and DFU-1000. Neither system has been evaluated for
effectiveness in the collection of viruses. Furthermore, decontamination methods have
not been evaluated for these systems after use in sampling for a viral agent.

MS2 bacteriophage was used as a surrogate virus. Aerosolized MS2 was released into a
12 m3 exposure chamber. High and moderate airborne concentrations of MS2 were
evaluated. Low volume impingers were used for comparative purposes as well. Samples
were analyzed using plaque assay and polymerase chain reaction (PCR).

At high viral loads the XMX/2L-MIL and DFU-1000 achieved collection effectiveness
equal to or greater than the low volume impingers. At moderate levels of airborne viral
load, the XMX/2L-MIL was capable of collecting viral quantities within 25% of the
quantities collected by the low volume impingers. The DFU-1000 achieved marginal
collection effectiveness of virus at moderate concentrations compared to the XMX/2LMIL and is considered to be unreliable in the quantification of viral agent at moderate
levels and below. The DFU-1000 and XMX/2L-MIL were capable of collecting
detectable MS2 with PCR analysis at all concentrations. Ten percent sodium
hypochlorite (commercial bleach) solution effectively decontaminated MS2.
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HIGH VOLUME AIR SAMPLING FOR VIRAL AEROSOLS: A COMPARATIVE
APPROACH

I. Introduction

Viral Disease and Biowarfare Overview
Viral disease outbreaks have been the largest contributor to recent disease pandemics
including the Severe Acute Respiratory Syndrome (SARS) virus, the H5N1 avian
influenza, and most recently the H1N1 swine flu. These disease outbreaks have caused
widespread concern and often weigh heavily on public health resources. The 2009
outbreak of the H1N1 strain alone has resulted in 9,079 hospitalizations and 593 deaths
worldwide as of September 4, 2009 (CDC, 2009). In a nine month period from
November 2002 to July 2003, over 8,000 people were infected with the SARS virus. Of
those infected, 774 died, giving SARS a mortality rate of 9.6 percent (WHO, 2004).
Each of these recent viral disease outbreaks is capable of airborne transmission by viral
aerosol, thus greatly increasing the incidence of new cases and rapidly facilitating their
global spread. Localized viral disease epidemics have also resulted in severe impacts to
Air Force training and operations. Outbreaks of Adenovirus Subtype 14 have persistently
affected the basic training operations at Lackland Air Force Base, Texas. These
outbreaks resulted in two fatalities and numerous hospitalizations since 2007 and
continue to cause illness in the training population. New viruses and mutations of
existing viruses are expected to present a challenge for the foreseeable future.
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In addition to the emergence of naturally occurring viral disease causing agents,
numerous potential bioterrorism agents are also capable of dissemination by viral aerosol.
These agents include smallpox, viral hemorrhagic fever agents, and Venezuelan Equine
Encephalitis (VEE). The use of smallpox virus as a biological warfare agent can be
traced back as early as the eighteenth century when blankets and clothing items from
smallpox patients were given to Native Americans during the French and Indian War
(Martin, Christopher, & Eitzen, 2007). Consideration of smallpox and other viral agents
as potential biological weapons continued into the modern era. The Soviet Union pursued
a large clandestine program during the cold war that included weapons research on
numerous viral agents including smallpox, Marburg, and VEE. These agents were
prepared in quantities sufficient for use in intercontinental ballistic missiles to
disseminate the aerosolized virus over a large geographical area (Alibek, 1999). AlQueda and other terrorist organizations also have expressed interest in developing,
acquiring, and using biological weapons. An Iraqi Al-Queda website expressed such
interest with the following post in 2005:
Biological weapons are considered the least complicated and the easiest to
manufacture [of] all weapons of mass destruction. All the information
concerning the production of these weapons is readily available in academic
books, scholarly publications and even on the internet….In addition to the ease
of production, these weapons are also considered to be the most affordable. With
$50,000 a group of amateurs can possess a biological weapon sufficient to
threaten a superpower. It is for this reason that biological weapons are called the
poor man’s atomic weapon (Salama & Bursac, 2009).

2

Disease Life-Cycle Models, Transmission, and Control
The life cycle of all infectious disease can be evaluated through the use of the HostAgent-Environment (HAE) triad model. This model provides the basic framework for
preventing the spread of infectious disease. The host is defined as the susceptible
population to a particular disease causing pathogen or agent. Agents can be altered and
concentrated from their natural form to make the host more susceptible or to overcome
the host resistance. Particularly virulent strains of Marburg virus and VEE were selected
in the Soviet biological weapons program for these purposes (Alibek, 1999). Use of the
HAE framework might also include strengthening the resistance of a host through
immunization. The environment portion of the HAE model is defined as the medium that
the agent can be transferred from host to host, typically through a vector or fomite.
Chlorination of water supplies to create unsuitable conditions for waterborne agents is a
method in which the environmental portion of the HAE framework is used. Quarantine
and isolation can also be used in the context of the HAE model by restricting the infected
host from an environment where infection of other susceptible hosts could occur.
Another important disease model in understanding the behavior of infectious disease is
the Natural History of Disease, which divides all infectious disease into two basic phases:
prepathogenesis and pathogenesis. The prepathogenesis period begins with the agent in
its environment and before a host is exposed. The prepathogenesis period continues after
exposure during a period where the agent is adapting to the host. In this phase, infection
can be prevented as the host’s immune response may prevent the agent from fully
adapting to the host. Once the host is infected, the pathogenesis period begins.
Symptoms do not appear at first during latency or incubation. The early portion of the
3

pathogenesis period is very critical in preventing the spread of disease since the infected
host shows no appearance of infection, but can often introduce the agent to new hosts.
Once infected hosts are identified or infectious pathways in the environment are known,
methods can be devised to isolate the infected hosts or prevent the interaction between
susceptible hosts and disease pathways in the environment. If conducted properly these
quarantine and isolation procedures are shown to be very effective. Meltzer et al.
modeled potential response strategies to a release of smallpox as a biowarfare agent.
Quarantine and isolation was shown to be capable of eliminating an outbreak of
smallpox. The authors assumed that 50 percent of an infected population could be
isolated starting 30 days after agent release and projected that by 240 days post release no
new cases would occur (Meltzer, Damon, LeDuc, & Millar, 2001). To ensure effective
isolation, the infectious agent must be unable to transfer from infected hosts to a
susceptible population outside of the isolation areas. Effective levels of isolation and
quarantine can be particularly difficult for airborne agents that can be quickly spread on
aerosolized droplets or particles. The use of an aerosolized viral agent in biowarfare
could drastically increase the complexity of protecting potential hosts since the viral
agent would be widely disseminated prior to the initiation of a response. Determining the
size of a cordon or initial quarantine area would be a necessary step in initial response to
such an incident. This step could be accomplished with an effective air sampling
methodology.

Direct environmental controls have also been proposed for localized outbreaks of viral
disease. The Air Force has proposed using ultraviolet radiation inside the ventilation
4

systems in high risk areas at Lackland AFB to control the airborne dissemination of
Adenovirus. However; there is no field deployable sampling methodology available for
viruses that would be able to determine if these controls would be effective or necessary.
Quarantine, isolation, protective equipment, and environmental controls must be able to
reduce host exposure to a level that is below the infectious dose for a specific viral agent.
This infectious dose varies according to the agent in question and the route by which
exposure occurs. To be effective, a sampling method for viral aerosols must be capable
of detection at levels at or below the minimum infectious dose.

Biological Sampling and Detection Equipment
A wide range of equipment is marketed for the detection and quantification of biological
aerosols. Much of this equipment is also advertised as being capable of collecting
airborne viruses. Collection methods and devices for the sampling of viral aerosols can
be broadly grouped into two categories: high volume and low volume. High volume
methods typically collect air samples at rates of over 40 liters per minute, and some are
capable of sampling rates of up to 1,000 liters per minute. Because of the low airborne
concentrations expected in an outdoor environment, air sampling devices intended for use
in response to biological warfare agents are almost exclusively high volume. The quick
collection of a large volume of sample allows for fast confirmatory analysis for
immediate response personnel. Low volume devices operate at airflows below 40 liters
per minute and are more frequently used in laboratory or field experimental analysis
where collection and quantification of aerosolized biological specimens is necessary.
Sampling devices for bioaerosols can also be grouped by their means of collection.
5

These broad categories include liquid impaction, solid impaction, and filter collection
(Verreault, Moineau, & Duchaine, 2008).
Solid impaction methods include Andersen samplers, slit samplers (slit to agar samplers
are an example), and cyclone samplers. While the efficiency of solid impaction samplers
is typically higher for larger particles; some, such as the Andersen sampler, can be used
for particle sizes as small as 0.65 micrometers (Verreault, Moineau, & Duchaine, 2008).
Some solid impaction samplers also provide additional capabilities not available for
liquid or filter collection, such as particle sizing (Andersen sampler) and time resolution
(Slit to agar). Illustrations of these solid impaction devices are shown in Figure 1.

Figure 1: Solid Impaction Aerosol Collection
(Verreault, 2008. Reproduced with Permission from American Society of Microbiology)

Liquid collection methods have been used for bioaerosol collection since the 1950’s, and
involve the use of an impinger to capture viruses. Impingers are the most commonly used
type of sampler in the collection of airborne viruses. Classic impinger systems such as
6

the All Glass Impinger (AGI) place an airflow exit at a set distance of 4 mm for the AGI4 and 30 mm for the AGI-30 from the bottom of a fluid vessel. This placement creates a
sharp turn in the streamline of the airflow that traps particles in the collection fluid.
More recently, a new form of liquid impinger, the swirling aerosol collector, came into
use for the collection of viral aerosols. The swirling aerosol collector is expected to
retain more viability in the collected sample than other impinger methods. This impinger
is manufactured by SKC, Inc. and marketed under the trade name Biosampler. An
illustration comparing the swirling aerosol collector with a conventional impinger, the
AGI-30 is shown in Figure 2.

Figure 2: Liquid Impinger Models
(Verreault, 2008. Reproduced with Permission from American Society of Microbiology)

Filter aerosol collection is often more efficient than other sampling methodologies for
collecting small particles with aerodynamic sizes less than 500 nanometers (Verreault,
Moineau, & Duchaine, 2008). However; filter collection presents several limitations for
their use in sampling for airborne viruses. Filters are known to cause structural damage
7

to the collected virus and desiccate the sample, thus reducing the amount of viable virus
available for culture analysis (Verreault, Moineau, & Duchaine, 2008). Additionally, the
use of filters for collection can pose difficulties in sample analysis. Many sample
analysis methodologies require a liquid medium; therefore, the sample must be extracted
from the filter into the liquid media. The tendency of the filter to retain the sample (Cox
& Wathes, 1995) can increase the challenges of this extraction. This extraction process
could significantly reduce the amount of sample available for analysis.

Air sampling for biological agent identification exclusively employs high volume air
sampling equipment. This requirement for high volume sampling equipment is driven by
the relatively low air concentrations expected in a response area and the need for fast
collection of a sufficient quantity of sample for analysis. Many low volume systems,
such as those described above, have been evaluated for collection of viral aerosols in a
wide range of studies. So far, most high volume systems have not been evaluated for
effectiveness in the collection of viral aerosols. This lack of evaluated effectiveness
creates a major obstacle to the reliable and confident use of these systems in response to
an aerosolized viral agent.

Air Force Use of Biological Sampling Equipment
The United States Air Force has employed biological agent detection at high risk sites for
over 10 years. This capability is still in place with the Air Force use of the Portal Shield
monitoring system. The Portal Shield, deployed in high risk areas throughout the world,
provides continuous agent monitoring at a fixed site. In the period immediately
8

following the attacks on September 11, 2001, and the anthrax letter incidents in
September and October 2001, the Air Force scrambled to acquire air sampling equipment
capable of mobile response to an incident involving biological weapons. The two
systems purchased by the Air Force for this purpose included the XMX/2-MIL,
manufactured by Dycor Technologies, Inc., and the DFU-1000 manufactured by
Lockheed Martin Integrated Technologies. The XMX was selected by the
Bioenvironmental Engineering community as their primary field portable sample method
for viral aerosols, while Civil Engineering Emergency Management personnel selected
the DFU-1000. These two instruments were purchased with the intent of responding to
an incident involving biological weapons. Very little investigation was made into other
potential uses, capabilities, or limitations associated with these samplers. Organizations
outside of the Air Force have used the XMX/2L-MIL and DFU-1000 for purposes other
than biological warfare response with varying degrees of success. This expanded use
prompted the United States Air Force School of Aerospace Medicine (USAFSAM) to
consider the using the XMX/2L-MIL and DFU-1000 to monitor for adenovirus and for
other responses involving other viral agents.

The XMX/2-MIL is a multiple stage collection method that pairs virtual impaction with
liquid impingement. Virtual impaction differs from conventional aerosol impaction in
that conventional impaction removes particles below a certain cutoff size, while virtual
impaction separates a single airflow stream into two airflows that are differentiated by
particle size. After passing through virtual impaction, airflow is divided into major and
minor flow streams. The major flow stream primarily contains particles smaller than a
9

certain cutoff size, while the minor flow stream primarily contains particles larger than
the cutoff size (Loo & Cork, 1988). The XMX/2L-MIL uses multiple virtual impaction
stages to concentrate a high volume of airflow into a low volume airflow consisting
primarily of particles in the respirable size range of 1 to 10 micrometers. The flow rate
entering the XMX is greater than 500 liters per minute, but is reduced into a secondary
flow of approximately 12.5 liters per minute. This concentrated secondary flow is then
transferred via a liquid impinger into a collection media. Typically sterile water,
phosphate buffered saline, or a user specified collection media, such as Remel M5, is
used for this final sample collection step.

The DFU-1000 is a high volume air sampler that employs filter collection as an aerosol
collection mechanism. The DFU-1000 is capable of sampling for long periods of time at
high rates of airflow up to 800 liters per minute. The DFU-1000 utilizes a standard 47
millimeter diameter polyester felt filter with a 1.0 micrometer pore size. This filter has
been evaluated for particle sizes as low as 100 nanometers and was shown to have a 75
percent collection efficiency for particle sizes of 100 nanometers (Lawrence, 2003). The
DFU-1000 is intended for indoor air sampling only however an updated version, the
DFU-2000, was developed to allow outdoor sampling. The DFU-2000 is a DFU-1000
with a protective housing, a mast extending up to 3 meters in height, and a pre-separator
to remove large particles or debris. These modifications allow for the DFU-2000 to
sample in harsh ambient conditions (JPEO-CBDX, 2008).
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While the XMX/2-MIL and DFU-1000 are widely deployed at most domestic and
overseas Air Force bases, most bases typically maintain only one or two of each system.
For this reason, the ability to use these devices multiple times at multiple sample
collection points is critical and multiple use capability is a major comparison criteria. In
order to provide this capability, the collection system used must be capable of
decontamination under field operating conditions. No study employing infectious viral
agent has been published to determine if either the XMX/2-MIL or DFU-1000 is able to
be decontaminated in the field after exposure to a viral agent.

Biological Analysis Methods
Analysis methods for viral samples include plaque assay and polymerase chain reaction
(PCR) analysis. Plaque assay was originally developed for the measurement of
bacteriophage stock, but has since been applied to the study of mammalian virus (Adams,
1959). Plaque assays function by culturing a virus sample on a plate consisting of cell
nutrient agar and cells that are susceptible to infection. The cell material utilized depends
on the virus for which the analysis is intended. The plaque assay method provides a
quantitative measure of viable infectious virus present in a sample. However; several
limitations prevent plaque analysis from being used as the preferred analysis method for
biological response to a viral agent. These limitations include the time lapse required to
culture the plates and the availability of infectious virus to perform analysis. In order to
use plaque assay as a primary or confirmatory analysis method, recovery of viable viruses
from an aerosol collector is required. These limitations severely restrict the use of plaque
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assay in a biological agent response. Nevertheless, plaque assays can still be effective for
confirmation analysis when a positive test result is obtained using other methods.

PCR analysis provides a solution to the limitations presented by plaque assay. PCR
allows for the detection of viral DNA, and functions by replicating a small amount of
DNA in a sample to make multiple copies which then allows for detection to occur. This
technique requires the addition of “short DNA strands called primers to target specific
sequences in sample DNA” (Ty, 2007). The addition of the primers often requires that
some sequence of the sample DNA be known (Bermingham & Luettich, 2003). This
limits the use of PCR to applications where a specific agent or group of specific agents is
suspected. The Air Force employs the Joint Biological Agent Identification and
Diagnostic System (JBAIDS) to provide PCR analysis capability to its Laboratory
Response Teams (LRT). JBAIDS is manufactured by Idaho Technology Incorporated,
and is capable of identifying 10 known biological agents. Results can be provided in a
period of 40 minutes (Wilson, 2006). The primary limitation of PCR is that it detects
only the viral DNA or RNA present rather than the infectivity of the virus. Therefore;
PCR cannot distinguish between deactivated virus and infectious virus. This limitation
makes PCR analysis unsuitable to evaluate the effectiveness of environmental controls
for viral aerosols such as those proposed for the control of adenovirus.

Laboratory Evaluation of Sampling Methodologies
Most laboratory studies for airborne viruses are conducted using an exposure chamber.
The use of an exposure chamber for initial evaluation of viral aerosol collection methods
12

allows for the study of aerosols under controlled atmospheric conditions for extended
periods and over multiple trials. The use of an exposure chamber also allows the aerosol
to be continuously mixed and prevents the gravitational settling of particles during a trial
(Verreault, Moineau, & Duchaine, 2008). These laboratory evaluations can then be
followed with field testing in order to comprehensively evaluate a sampling methodology
under less controlled conditions.

Thesis Objectives and Limitations
This study seeks to determine if the XMX/2-MIL and DFU-1000 meet the criteria
required for their use in response to the malicious release of a viral agent or during an
outbreak of a viral disease. These criteria include recovery of viable virus, limits of
detection or quantification, and field decontamination. These sampling systems will be
evaluated simultaneously and compared based on these criteria. This will provide
information to responders in selecting the equipment and sampling methods to conduct
air sampling for viral agents. This study will be limited to evaluating the XMX/2-MIL
and DFU-1000 only. Other high volume air sampling devices are not widely available to
Air Force personnel. The XMX/2L-MIL and DFU-1000 will be evaluated in a laboratory
exposure chamber. Field testing will not be conducted as part of this project. This study
will test the XMX/2L-MIL and DFU-1000 using a single sample duration and collection
media. While the use of different sample durations and collection media could affect the
performance of the equipment, time and resources did not allow these parameters to be
evaluated in this study. Ambient factors during sampling were not varied during
analysis. Ambient factors such as temperature and humidity have been widely studied in
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previous viral studies and found to have significant impact on the infectivity of viruses
(Verreault, Moineau, & Duchaine, 2008). Further laboratory studies and field testing will
be necessary to fully evaluate the effectiveness of these sampling methodologies under all
conditions. In the decontamination portion of this study, only field decontamination was
evaluated. Laboratory grade decontamination such as autoclaving or heat sterilization is
likely to be more effective. In practice, these laboratory grade methodologies are
unlikely to be available for field use in a response. Analysis was limited to quantification
by viral plaque assay with presence/absence analysis using the JBAIDS. Quantitative
and semi-quantitative PCR analysis was not performed as part of this study. These
quantitative PCR methods are unavailable to Air Force LRTs for analysis of samples
collected from the XMX/2L-MIL and DFU-1000 in response to a biological agent, and
would not be representative of Air Force field capabilities.

The Air Force does not typically evaluate biological sampling equipment acquired from
commercially available sources. Information is provided by the manufacturer and
evaluated by the organization considering the purchase. This acquisition method is
classified as commercial off the shelf (COTS) (Wilson, 2006). While this process is
considerably faster and less involved than other acquisition processes, it fails to fully
assess the capabilities and limitations of the equipment. Furthermore, the Air Force is
reliant on the accuracy of manufacturer information. This introduces the potential for
biased or incomplete information to be used during purchasing and equipment
application. This study provides a limited, independent evaluation of two biological
sampling systems and should provide insights on the effectiveness of using Air Force
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resources to independently evaluate future biological equipment acquisitions and
deployment applications of existing equipment.
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II. Literature Review

Overview
This section seeks to review scientific literature pertinent to sampling for aerosolized
viral agents. Many focus areas are presented including historical studies on viral agents of
interest, factors related to aerosol particle size, external factors that affect sampling, use
of viral surrogates, previous studies involving high and low volume viral air sampling,
and decontamination of sampling equipment. Studies conducted both in the field and in
laboratory environments will be reviewed. Currently, Air Force biological air sampling
equipment employs dry filtration, virtual impaction, and collection by liquid impinger.
This review will provide more emphasis on these sample collection methods, and on
factors influencing their use. The literature reviewed will further the objective of
applying laboratory methods to comparatively evaluate operational equipment for the
sampling of viral aerosols. The literature review for decontamination methods will focus
on hypochlorite solution use for decontamination, and emphasize studies previously
conducted by USAFSAM.

Air Sampling Background
Air sampling is a critical component of an evaluation to support making a health risk
assessment following the release of a biological, radiological, or chemical agent. Air
sampling is the primary method to determine the “nature, concentration, and
pathogenesis” of airborne microorganisms (Verreault, Moineau, & Duchaine, 2008).
However; the science of air sampling for viruses is developing, particularly with regard to
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the use of high volume air sampling methods. Numerous studies have been conducted on
a variety of sampling methodologies and analytical techniques resulting in the
identification of many “advantages and pitfalls” (Verreault, Moineau, & Duchaine,
2008). Detection and quantification of an airborne virus “is dependent on three primary
factors: the concentration of airborne virus, the collection efficiency of the air sampling
system, and the analytical sensitivity of the diagnostic assay” (Hermann, Hoff, Yoon,
Burkhardt, Evans, & Zimmerman, 2006). Unfortunately, many of these techniques have
not been fully explored for many viral agents of interest or for high volume air samplers
currently in operational use by the Air Force. Due to the limited breadth and depth of
work on the subject of air sampling for viruses, “there are currently no standard methods
for the recovery and detection of specific pathogens… The lack of guidance requires that
sampling methods be optimized and validated for each target pathogen. (Hermann, Hoff,
Yoon, Burkhardt, Evans, & Zimmerman, 2006). Such optimization and validation is
necessary for all pathogens of interest, including viral agents, and for all sampling
equipment currently in the Air Force inventory, including the XMX/2L-MIL and the
DFU-1000.

Historical Studies of Interest
Air Sampling for Variola
Disease researchers have attempted air sampling in cases involving airborne viruses for
over 60 years. Most of these early attempts involved sampling in areas where airborne
viruses were considered likely to be found, such as in the immediate vicinity of a patient
confirmed to have a viral disease. Two early studies with implications in the study of
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biological warfare agent sampling involved air sampling at a smallpox hospital in
Madras, India. These studies, conducted in 1960 and 1963, involved air sampling in
close proximity to smallpox patients at various stages of disease progression and at
various points throughout the hospital and patient wards. The 1960 study, conducted by
Meiklejohn et al., involved the collection of 38 separate air samples collected using a
crude filter consisting of a glass tube packed with dry cotton. Sample analysis was
conducted by inoculating chicken embryos with the collected sample. This analysis
method allowed for the detection and crude quantification of infectious virus (in pock
forming units), assuming the presence of sufficient quantities. Both the air sample
collection and analysis methods had been tested experimentally in a laboratory
environment and shown to be effective for the detection of aerosolized vaccinia
(Meiklejohn, Kempe, Downie, Berge, St. Vincent, & Rao, 1961). Laboratory studies
indicated that liquid impinger collection were four times more efficient in the collection
of virus than using dry cotton. Aggressive sampling techniques were used in many of the
air samples, such as locating the sampler 12 inches from the mouth of an acutely ill
patient and sweeping scabs directly underneath the sample collection point (Meiklejohn,
Kempe, Downie, Berge, St. Vincent, & Rao, 1961). Despite these aggressive techniques,
variola recovery from air samples was relatively ineffective. In the 1960 study, only one
sample of the 38 collected produced a positive result for variola and even then in small
quantities (Meiklejohn, Kempe, Downie, Berge, St. Vincent, & Rao, 1961). The 1963
study used an all glass impinger with liquid collection media instead of a dry filter, but
was only modestly more successful. Ten impinger samples out of 52 collected resulted in
the detection of Variola major (Downie, Meiklejohn, St. Vincent, Rao, Sundara Babu, &
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Kempe, 1965). The overall low level of detection in the air samples was attributed to the
lack of sensitivity of the sampling methodology and potentially due to environmental
conditions, such as rapid air dilution in the hospital. Variola recovery from surface swabs
on pillows, bed sheets, and from settling plates was more effective with a majority of
these samples yielding infectious variola. These results indicate that swabbing can be an
effective recovery technique for the detection of viral contamination. Additionally,
swabbing could also allow for the quantification of virus containing particles that have
settled from the air.

Air Sampling for Adenoviruses
Air sampling was also attempted for adenovirus in 1967. This study, conducted by
Artenstein et al. on military patients with confirmed adenovirus infections, used a high
volume electrostatic precipitator with a cyclonic pre-impactor system capable of
sampling approximately 10,100 liters per minute (Artenstein, Miller, Lamson, & Brandt,
1968). Similar to the smallpox studies, Artenstein et al. used aggressive sampling
techniques in this study. Aggressive techniques included having an infected patient
cough directly over the sampling orifice and having the patient stand in a room and cough
frequently for 5 minutes while the air sampler was running. Of the four adenovirus
sample runs, three produced viable virus. This study can be applied to the Air Force
requirement for a system capable of sampling for viable adenovirus because it
demonstrates that in sufficient concentrations, environmental recovery of viable
adenovirus from an air sample is possible.
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Implications of Historical Studies to Modern Air Sampling Equipment
Many of the modern high volume air sampling systems for bioaerosols employ collection
methods similar to those found in the historical studies. For example, wet-walled
cyclones are used in high volume systems to collect respirable bioaerosol particles. Wetwalled cyclone collection has many similarities to the pre-impactor used by Artenstein
eliminate large, irrespirable, particles from final sample collection. Furthermore, many
of the sampling methods used in the smallpox field studies form the basis for much of the
biological air sampling equipment used today. For example, the dry cotton packed tubes
used by Meiklejohn to collect samples for smallpox are a crude dry-filter sampling
system similar in principle to the current DFU-1000 used by the Air Force. These early
studies demonstrate that the recovery of viable airborne virus is possible provided the
concentration of virus present is sufficient. Some limitations of these early studies have
been addressed today. For example, sample analysis methods for both the smallpox
studies and the adenovirus studies required infectious virus to be recovered by the air
sampling method. Detection techniques for viral DNA and RNA such as polymerase
chain reaction (PCR) were unavailable in the 1960’s and do not require infectious virus
for detection. The smallpox studies also demonstrate the difficulties in applying
sampling techniques to field studies even when the sampling techniques are found
effective in a laboratory setting. Many of these difficulties persist in field applications of
sampling methodologies today. Studies on smallpox could not be repeated today since
research on active variola is strictly controlled. Therefore these studies provide the only
direct information available on air sampling for this important viral agent. Probably the
most important observation of the air sampling studies for smallpox was the effectiveness
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of liquid collection compared to dry filter collection. The liquid impinger collected
viable smallpox virus in 12 out of 52 samples (Downie, Meiklejohn, St. Vincent, Rao,
Sundara Babu, & Kempe, 1965), while the dry filter method collected viable smallpox
virus in only 1 out of 38 samples (Meiklejohn, Kempe, Downie, Berge, St. Vincent, &
Rao, 1961). This disparity suggests that liquid collection for some viral agents could be
more effective than dry collection methods. The limited detection of virus in both of
these smallpox studies also reveals the difficulties in conducting air sampling for Variola,
and the relatively high airborne concentrations of viable virus required to generate a
detectable, much less quantifiable, result. These details underscore the need for
biological air sampling systems to be robustly evaluated for their effectiveness in the
collection of viral agents. This need should extend to the sampling equipment currently
used by the Air Force as well.

Particle Characteristics and Viral Aerosols
Particle size has been shown to be one of the most important characteristics related to the
airborne residence time of the viral aerosol, its potential for infection, and the efficiency
at which the virus can be recovered during sampling. Therefore the particle size of an
aerosol containing a biological agent must be fully considered in both laboratory and
field evaluation of sampling equipment.

Health Assessment Considerations Regarding Particle Size on Air Sample Collection
The health impact of aerosolized particles “is size dependent”, and measurement of
particle size distribution should be included in field studies and “controlled in laboratory
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studies of virus particles” (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas,
2005). The nose and upper airways prevent airborne particles greater than 10
micrometers from entering the respiratory system. For this reason, most air sampling
equipment for bioaerosols strip out particles larger than this 10 micrometer cutoff. The
study of aerosolized biological agents has largely centered on particle sizes in the
“respirable” size range of less than 10 micrometers to provide a proper representation of
human exposure. Less is known or understood at the submicrometer end of the particle
size distribution. Submicrometer sized particles likely play a larger role in morbidity
than previously considered (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas,
2005), and are not efficiently collected by most high volume air sampling equipment.
The respiratory deposition probability of various particle sizes is shown in Figure 3. It is
important to note that even a 0.3 micrometer sized particle has a 15 percent probability of
deposition in the human respiratory tract (Maynard & Kuempel, 2005). For this reason,
air sampling equipment for viral agents should be able to include a reasonable collection
efficiency of submicrometer particles to better characterize human exposure to a viral
aerosol. Preferably, the collection efficiency for submicrometer particles would be at
least equal to the deposition probability in the respiratory tract.
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Figure 3: Respiratory Deposition Probability
(From Maynard & Kuempel, 2005. Reprinted with kind permission from Springer Science)

Air Sampling and Particle Size Considerations
Development of biological detection equipment has centered on the ability of the
equipment to limit air sampling to the respirable size range. This includes the equipment
currently inventoried by the Air Force.

The XMX/2L-MIL limits sample collection

primarily to the 1 to 10 micron size range (Tucker, 2005), and has very limited collection
effectiveness in the collection of submicrometer particles. Specific information on the
collection efficiencies of the XMX/2L-MIL is available through USAFSAM. The DFU1000 is a filter collection system and collects particles above the minimum collection size
of the filter. However, particle collection can extend to particle size ranges significantly
below the pore size of the filter. The standard filter provided with the DFU-1000 is a
polyester felt filter with a 1 micron pore size and has a reported efficiency of
approximately 75 percent for 100 nanometer sized particles (Lawrence, 2003). Although
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it is unclear if these efficiencies reported by Lawrence consider the high velocity air flow
conditions produced across the filter by the DFU-1000 during sample collection.
Regardless, high efficiencies would not be unexpected for the collection of
submicrometer sized particles. Filters are commonly used in the sampling of fine viral
particles, particularly for particle sizes less than 500 nanometers (Verreault, Moineau, &
Duchaine, 2008). Additionally, low volume liquid impinger sampling systems have also
been evaluated for their collection efficiency of micrometer and submicrometer particles,
including the AGI-30 and the Biosampler. The reported collection efficiencies for these
systems are included in Table 1.

Particle Size
(Microns)
0.3

69

Biosampler Collection Efficiency
(%)
78

0.6

71

88

0.8

72

91

1.1

82

92

1.7

93

93

2.0

95

95

AGI-30 Collection Efficiency (%)

Table 1: Particle Collection Efficiency of AGI-30 and Biosampler From Willeke et al., 1998

Particle Composition of Viral Aerosols
Virus containing particles consist of a variety of constituents, much of which is inorganic
(Verreault, Moineau, & Duchaine, 2008). For this reason, the virus accounts for very
little of the agent containing particle and a negligible portion of the aerosol. Also, the
addition of virus to experimental aerosols has little impact on the size characteristics of
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the aerosol when compared to the suspension media or the method used to generate the
aerosol (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005). Free viruses
are uncommon in the environment since particles tend to form aggregates very rapidly
when airborne (Verreault, Moineau, & Duchaine, 2008). This tendency, along with the
binding of virus within droplets and particles, allows for the air sampling of virus
particles without the need to collect the ultrafine individual virons. The importance of
submicrometer sized viral particles in natural viral aerosols is not well understood, but is
likely to have a strong affect on the health risks relating to human exposure.
Furthermore, the majority of airborne virus containing particles may be submicrometer
sized (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005). Hogan’s
observation has been verified in other viral particle studies as well. In a study of exhaled
influenza virus particle sizes conducted by Fabian et al. on patients infected with
influenza A and B, approximately 70 percent of particles in exhaled air were less than 0.5
micrometers in size and 87 percent were less than 1 micrometer in size. Exhaled
influenza containing particles greater than 5 micrometers were very rarely observed.
Fabian’s study indicates that fine particles of less than 1 micrometer may be a major
contributor in disease transmission for influenza (Fabian, et al., 2008). Studies on other
viral diseases have yielded different particle size information. For example, livestock
viruses such as Foot and Mouth virus and Aujeszky’s disease virus were mostly
contained in particles greater than 3 micrometers in size (Verreault, Moineau, &
Duchaine, 2008). Particle or droplet size may significantly impact the airborne viability
of virus in a aerosol. As shown in Figure 4, the droplet nucleus, including the viruses in
an aerosol droplet, become more exposed to environmental factors as the droplet dries
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out. The final size of the droplet nucleus may also be directly related to the relative
humidity. This is particularly true in the study of artificially produced viral aerosols in an
exposure chamber.

Figure 4: Droplet Evaporation in a Viral Aerosol
From Verreault et al., 2008. Reproduced with permission from the American Society of
Microbiology.

Artificially produced aerosols, such as those used in controlled chamber studies, are not
studied in the presence of other aerosols that may be present in a natural environment.
This condition prevents “binding of the nebulized particles”, and allows particle size to
be “influenced only by the size of the droplet created by the nebulizer and the solute
concentration” (Verreault, Moineau, & Duchaine, 2008), which may not represent
behavior in a natural environment. This factor may limit field use of aerosol collection
data gathered in the laboratory chamber setting. For this reason, air sampling studies
conducted in a chamber environment should consider these limitations before applying
laboratory generated data for field use. This limitation should be applied to laboratory
evaluation of Air Force high volume air sampling equipment as well.
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Particle Size and Settling Characteristics
The particle size of a viral aerosol is the key parameter in determining the settling rate
and, consequentially, their duration in the airborne environment. Particle sizes of 100
micrometers settle from a drop height of 8 feet in approximately 8 seconds, while 1
micrometer particles require 19 hours to settle. Submicrometer sized particles can remain
airborne for several months or longer (Utrup & Frey, 2004). The slow settling
characteristics of 1 micrometer and smaller particles allows for airborne exposure to
occur long after the aerosol is disseminated in an area. This feature also allows aerosols
comprised of submicrometer particles to be carried for longer distances after
dissemination and leads to larger areas of exposure risk. Dilution and environmental
degradation of the aerosol may reduce these health risks; nonetheless, a high volume air
sampler would need to collect a reasonable fraction of these micrometer and
submicrometer sized particles in order to fully assess health risk.

Measurement of Particle Size Distribution of Viral Aerosols
A variety of equipment is available to measure particle size during aerosol studies,
including real time measurement devices such as particle spectrometers and gravimetric
devices such as cascade impactors. Cascade impactors use a series of impaction stages
with descending particle size cutoff points. The cutoff size points are “determined by the
velocity of air through the nozzle and the distance of the nozzle from the collection
surface” (Cox & Wathes, 1995). These cascade impactors pre-date the real time
methodologies and are typically used as the “gold standard” in the development of real
time methods. An evaluated method is the aerodynamic particle sizer (APS)
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manufactured by TSI. The APS measures particle size by “determining the time-of-flight
of individual particles in an accelerating flow field” and is capable of measuring particle
size distributions in a particle size range of 0.5 microns to 20 microns (Peters & Leith,
2003). The APS, model 3321, was evaluated by Peters and Leith for collection efficiency
over a range of particle sizes from 1 micron to 4 microns. These efficiency evaluations
were conducted by comparing particle mass data obtained from the APS with the results
of particle collection using a cascade impactor. Counting efficiency for particle size
ranges of 1 to 3 microns was approximately 45% for the TSI 3321 and approximately
60% for particles in the 4 micron size range. Despite these lower overall counting
efficiencies, the particle size distribution produced by the TSI 3321 was similar to the
size distribution generated using data from a cascade impactor. This is primarily due to
the relatively consistent efficiency over the range of particle sizes evaluated (Peters &
Leith, 2003). This study demonstrates that the APS data can be used to determine a
particle size distribution, but data on total particle load likely requires adjustment.
Another commonly used instrument for particle size analysis is the Grimm Technologies
portable aerosol spectrometer (PAS) model 1.108. The PAS divides a particle size
distribution into 16 size channels, while the APS divides the particle size distribution into
52 size channels (Peters, Ott, & O'Shaughnessy, 2006). Both the PAS and APS can count
particles as large as 20 microns. One key advantage of using the PAS for particle size
analysis in the study of a viral aerosol is that the Grimm provides particle size
distribution data for particles as small as 0.3 microns. The APS distribution data has a
lower particle size counting limit of 0.5 microns (Peters, Ott, & O'Shaughnessy, 2006).
The accurate measurement of the particle size distribution is essential in the laboratory
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evaluation of air sampling equipment. These measurements ensure that artificially
generated aerosols used in a chamber sufficiently represent particle sizes that may be
present in the environment. The evaluation of Air Force high volume air sampling
equipment should incorporate particle size measurements that are as accurate as possible
for both micrometer and submicrometer particles.

External Factors on the Collection of Viral Aerosols
Many environmental factors can impact the behavior and sampling characteristics of
aerosolized viruses. Factors that are particularly important to the behavior of aerosolized
virus include relative humidity and temperature. Levels of ultraviolet radiation can
significantly impact the viability of aerosolized viruses in an outdoor environment. As
discussed earlier, the particle size and composition of a virus containing droplet can be
greatly affected by the relative humidity (Verreault, Moineau, & Duchaine, 2008). This
allows the size of particles in a chamber to be increased or decreased through the
adjustment of relative humidity. Many viruses also exhibit different infectivity
characteristics as the relative humidity is changed, which will be discussed further in the
surrogate viruses section. “The stability of certain infectious airborne viruses” is also
influenced by temperature, with certain viruses exhibiting greater infectivity at lower
temperatures (Verreault, Moineau, & Duchaine, 2008). This effect on virus stability was
shown to be minimal for certain bacteriophages, such as MS2, when aerosols were
generated using tyrptone broth instead of salt solution (Dubovi & Akers, 1970). For
these reasons, proper control of environmental conditions must be maintained in air
chamber studies during the evaluation of Air Force air sampling equipment.
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Furthermore, the impact of relative humidity on viral stability could be minimized by
impropriating tyrptone broth in the aerosol solution.

Infectious Concentration of Viral Aerosols
There is a dearth of published information available on the minimum aerosol
concentration required to produce an infection with viral agents of interest. One study
conducted by the United States Army Medical Research Institute of Infectious Diseases
(USAMRIID) exposed non-human primates to an aerosol of Ebola-Zaire, a CDC
category A agent. Two rhesus monkeys were exposed to a 400 PFU aerosol dose of
Ebola-Zaire. Both monkeys died or were euthanized after morbidity was observed
(Leffel & Reed, 2004). Although these lethal viral exposure levels would apply only to
an aerosol containing Ebola-Zaire, aerosol studies attempting to evaluate a limit of
detection for high volume air sampling equipment should attempt to achieve viral
concentrations below the lethal doses used in the Leffel study.

Viral Surrogates
The evaluation of air sampling methodologies for viral agents requires the aerosolization
of infectious virus. Since these agents can be very pathogenic to humans and capable of
airborne transmission, any study aerosolizing active pathogen typically requires operating
under bio-safety level (BSL) three or four. According to the American Biological Safety
Association, Smallpox and Marburg both require a BSL 4 level laboratory, while any
studies using VEE require a BSL 3 lab (ABSA, 2004). Providing this level of
protection, in addition to purchasing the agent itself, is very resource intensive and
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impractical under most circumstances (Foarde, Hanley, Ensor, & Peter, 1999). To
overcome these limitations, many studies use a surrogate virus to simulate a pathogenic
virus with similar characteristics.

Viral Surrogate Use in Previous Studies
Bacteriophages are often used as viral surrogates, including male specific 2 (MS2) and
T3 bacteriophage. Bacteriophages, as their name implies, use bacteria as their only host
organism, and represent no risk to humans, providing that the host bacteria are not
pathogens. MS2 has been used in studies to represent a variety of viral agents. Langlois
used MS2 as a surrogate for smallpox virus in the development of field deployable
biological detection equipment (Langlois, 2002). Another study by Foarde et al. used
MS2 as a surrogate for a variety of similar viral agents, including retroviruses and pox
viruses. Foarde noted that bacteriophages have aerosol characteristics similar to many
human viruses (Foarde, Hanley, Ensor, & Peter, 1999). Like to agents of interest, viral
surrogates can also be very persistent and hardy under experimental conditions. Utrup
and Frey used MS2 as a viral surrogate when they studied the fate of bioterrorismrelevant organisms in an indoor environment. Utrup and Frey observed that 52 percent of
the MS2 aerosolized in an exposure chamber remained viable in an aerosol form during
the 45 minute time frame of the study (Utrup & Frey, 2004). These successful previous
studies make bacteriophages a reasonably vetted and economical choice for the
evaluation of high volume air sampling equipment by the Air Force.
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Limitations to the Use of Viral Surrogates
The use of viral surrogates has many limitations. Hogan et al. observed that
generalizations should not be made between different virus types and that viability during
sampling can only be accurately determined when viruses are tested individually (Hogan,
Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005). Different viral types and
subtypes exhibit a broad range of structures and composition of nucleic acids. MS2,
despite its common use as a surrogate, cannot accurately represent the behavior of all
viral agents of interest (Tseng & Li, 2005).

Many studies have found that even viruses

of similar size and shape exhibit different behavior in aerosolization and collection.
Hogan et al. evaluated MS2 and T3 separately and found large differences in collection
efficiency performance between sampling for MS2 and sampling for T3. These
differences were observed for all three sampling methodologies evaluated including the
AGI-30 manufactured by Ace Glass Inc., the Biosampler swirling aerosol collector
manufactured by SKC, Inc., and the Fritted Bubbler. For example, the lower limit of
virus collection after 30 minutes of sampling for the AGI-30 using MS2 was
approximately 19 percent, while for T3 under the same conditions, the lower limit of
virus collection was observed to be approximately 1 percent (Hogan, Kettleson, Lee,
Bamaswami, Angenent, & Biswas, 2005). Tseng and Li evaluated sampling
characteristics for four different bacteriophages including MS2, Phi X174, Phi 6, and T7.
These bacteriophages represented a broad range of nucleic acid structure including single
strand RNA, single strand DNA, double strand RNA, and double strand DNA,
respectively. Viruses with a lipid envelope, such as Phi 6, are generally hydrophobic,
while viruses without a lipid envelope such as MS2, Phi X174, and T7, exhibit
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hydrophilic behaviors. This condition is particularly important during sample collection
since viruses with lipid envelopes are much more sensitive to stresses during sampling.
Tseng and Li also found that viruses with tail fibers, such as T7, exhibit greater
sensitivity to relative humidity than untailed viruses (Tseng & Li, 2005). Their studies
show that it is important to consider more than viral size and aerosol characteristics in the
selection of a surrogate virus. Surrogate virus selection should also consider the physical
structure of the virus and the nucleic acid type and structure. Similar to MS2, the
Marburg virus is also a single strand RNA virus, although significantly larger than an
MS2 bacteriophage (Elliott, McCormick, & Johnson, 1982). Poliovirus, similar in size to
MS2, is a single strand RNA virus, and is non-enveloped (Hogle, 2002). Verreault
observed that “structure of a virus alone cannot be used to predict the survival of the virus
under different environmental conditions” however (Verreault, Moineau, & Duchaine,
2008). For example, the stability of the St. Louis Encephalitis virus is not affected by
relative humidity (Verreault, Moineau, & Duchaine, 2008). Structurally similar
surrogates may not show this tolerance over broad humidity ranges. Therefore, even a
well chosen surrogate may not exhibit similar characteristics to the target virus despite
the similarity in size and structure. For this reason, evaluations of Air Force sampling
equipment should use multiple viral surrogates to ensure that bias is not introduced due to
characteristics specific only to a single agent.

Alternatives to the Use of Viral Surrogates
The broad range of studies using surrogate viruses in place of a pathogen show that the
use of surrogate viruses has value primarily because there is little alternative available at
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a reasonable cost and acceptable level of safety. The only alternative to using surrogate
virus is to use an inert particle of similar size, such as polystyrene latex beads.
Polystyrene latex beads were used by Hogan to evaluate the collection of submicrometer
particles by bioaerosol sampling equipment (Hogan, Kettleson, Lee, Bamaswami,
Angenent, & Biswas, 2005). While these inert particles can provide data to evaluate a
sampling method for a particle size range of interest, it is not possible to determine the
effect of the sampling method on virus viability. Air Force evaluations on air sampling
equipment should evaluate particle size collection efficiencies using inert particles
separately from studies on viral aerosols.

Low Volume Sampling Methods
Several low-volume sampling methodologies have been evaluated and described in
current literature for the collection of airborne virus. While low volume air samplers
have many limitations, their development and evaluation is necessary to determine the
relative effectiveness of other sampling methods, such as high volume samplers. Three
evaluated technologies include the AGI-30, the Biosampler, and the Fritted Bubbler.

Collection Mechanisms for Low Volume Air Sampling
The AGI-30 and Biosampler utilize a right angled collection tube to limit particle
collection sizes to those below a respirable size of approximately 10 micrometers. Liquid
collection devices, such as these, have an advantage over other collection methods since
most biological analytical methods require liquid media (Hogan, Kettleson, Lee,
Bamaswami, Angenent, & Biswas, 2005). The use of a liquid collection device prevents
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the need to transfer a sample into a liquid media after collection thus preserving more of
the sample for analysis. The disadvantage of liquid aerosol collection is loss of sampling
media due to evaporation. This fluid loss can result in the reaerosolization of virus and
potentially reduce the collection efficiency (Hogan, Kettleson, Lee, Bamaswami,
Angenent, & Biswas, 2005). The AGI-30 uses a 1 mm diameter nozzle that is placed 30
mm above the bottom of the collection vessel and 10 mm above the surface of the
collection media. This placement produces a sharp turn in the streamline of the airflow at
the outlet, forcing particles with higher inertia to penetrate the liquid and become trapped.
The Biosampler is a “swirling aerosol collector” that uses three 0.63 mm nozzles to
create a swirling action in the media which also causes particles to penetrate the fluid and
become trapped (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005).
Fritted bubblers are typically used in gas capture as opposed to bioaerosol particle
collection. Bubblers use a glass frit at the end of the collection tube where the air stream
contacts the media. This porous frit causes bubble formation that allows the interception
of particles through an impaction mechanism with the bubble. Very small particles will
also diffuse to the air-liquid interface of the bubbles thus allowing capture.

Evaluation of Low Volume Air Sampling Methodologies
A study conducted by Hogan et al. attempted to compare the collection efficiencies of
different bioaerosol collection devices, including the AGI-30, Biosampler, and Fritted
Bubbler. This study used MS2 and T3 bacteriophage solutions and atomized the viral
solution to create ultrafine particulate aerosols. This study is relatively novel in that it
compared the collection efficiencies for submicrometer particles and ultrafine particles
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with diameters of less than 100 nanometers (Hogan, Kettleson, Lee, Bamaswami,
Angenent, & Biswas, 2005). Prior studies had focused on aerosol particle sizes of
approximately one micrometer in diameter or larger. There is a concern that ultrafine
particles could transfer by diffusion through the alveolar membrane thus providing a
route of entry into the blood stream. The Hogan et al. study found that all three evaluated
samplers were inadequate in the sampling of ultrafine particles with collection
efficiencies below 10%. The Fritted Bubbler was the least efficient in the collection of
ultrafine particles and the AGI-30 was found to be the most efficient although still below
10%. All three samplers demonstrated sharp increases in collection efficiency as particle
diameter increases above 100 nm. Extremely small particles with diameters less than 30
nm showed an increase in collection efficiency as particle diameter decreases due to
tendency of these particles to diffuse into the media (Hogan, Kettleson, Lee, Bamaswami,
Angenent, & Biswas, 2005). However, most viruses are larger than this diffusive size
range. Hogan et al. also evaluated collection efficiencies of the samplers at different flow
rates. The manufacturer specified flow rate for all three samplers is 12.5 liters per minute
(lpm). The study found that found that for flow rates less than 2.5 lpm, very little media
depression occurs in the AGI-30 and the fluid remains motionless in the Biosampler, thus
preventing the desired swirling motion. Turbulent liquid motion is observed in the AGI30 at flow rates higher than 2.5 lpm and in the Biosampler at flow rates higher than 8.7
lpm. The collection efficiencies were evaluated at flow rates of 6.25 lpm and 12.5 lpm.
The AGI-30 and Biosampler were more efficient at 12.5 lpm, while the Fritted Bubbler
had higher efficiencies at 6.25 lpm. The three samplers were also evaluated for particle
collection efficiency and virus viability as a function of sampling time. The AGI-30 and
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Biosampler demonstrated relatively steady particle collection efficiency over time, while
the Fritted Bubbler shows an increase over time due to the deposition of particles in the
frit. The Fritted Bubbler also has a high rate of media loss resulting in a higher virus
concentration simply due to the evaporation of the fluid. MS2 loses viability in the AGI30 for sampling periods greater than 30 minutes, indicating that viral collection with the
AGI-30 should be limited to less than 30 minutes. There was very little correlation in the
viability of MS2, as compared to T3 indicating that generalizations cannot be made
across different viruses. Similar to previously conducted studies, such as those by Tseng
and Li, this demonstrates that viral surrogates may not accurately simulate pathogenic
viruses (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005). Hogan’s
study evaluates many of the potential variations associated with using liquid collection
devices for viral aerosol. Comparing Hogan’s results to those obtained in studies of
aerosol particles greater than 1 micrometer could prove valuable in assessing the entire
collection of a viral aerosol across the entire range of particle sizes. The paper did not
account for potential variation from different collection media since a single media,
phosphate buffered saline (PBS), was used as the liquid collection media for all sample
runs. The study did not account for collection efficiency variation due to changes in
temperature and humidity. The Hogan study is also limited in that it does not explore the
processes responsible for the low collection efficiencies observed. A study
commissioned by the Air Force Research Laboratory and conducted by Riemenschneider
et al. sought to determine the impact of reaerosolization in the sampling of viral aerosols
(Riemenschneider, et al., 2009). This study examined the AGI-30 and the Biosampler.
Similar to the Hogan study, flow rates and sampling time were varied, but used to assess
37

the impact of reaerosolization on sampling efficiency. Sample evaluations were also
conducted with an inert aerosol tracer, poly styrene latex (PSL), and live MS2 virus.
Similar to Hogan et al., the Riemenschneider study found that collection efficiency was
lower when flow rates differ significantly from the recommended 12.5 lpm, with higher
flow rates greatly increasing the reaerosolization of both virus and PSL. The
Riemenschneider study also used a single collection fluid, deionized water, as a
collection media. Riemenschneider was more thorough than the other authors in
explaining this selection over other collection media, such as phosphate buffered saline
(PBS), which is commonly used in liquid collection systems. The use of saline solutions
can create salt aerosols that can make it difficult to distinguish the reaerosolization of
virus (Riemenschneider, et al., 2009). The Biosampler was also found to have a
significantly lower reaerosolization rate as compared to the AGI-30; although sampling
durations greater than 30 minutes were found to increase the reaerosolization in the
Biosampler. Further studies should be conducted to determine the impact that longer
sampling durations have on virus viability, in addition to the affects of the collection fluid
selected. This observation also indicates that initial studies on air sampling equipment
should select a lower sampling time to minimize the effects of sampling durations on
liquid collection systems, and thus remove this potentially significant variable. Of the
three low volume samplers evaluated in these reviewed studies, only the AGI-30 and
Biosampler are widely described in published literature relevant to the sampling of viral
aerosols. Therefore, evaluation of high volume air sampling equipment should include
either an AGI-30, Biosampler, or both as a standard reference to compare collection of
virus particles.
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Collection Media
The collection media used in the air sampling of viral aerosols can also impact the
collection of virus. A study by Hermann et al. compared various additives to PBS. This
comparison was made to optimize a sample collection process for porcine reproductive
and respiratory syndrome virus (PRRSV). PBS is a media commonly used for impinger
collection methods. Hermann et al. compared the addition of 1% activated carbon, 0.5%
bovine serum albumin, and 20% ethylene glycol to PBS. Combinations of these
additives were evaluated as well. None of the additives tested had a significant impact of
the collection efficiency of virus, and all solutions and additives were within 10% of the
PBS results without additives. Ethylene Glycol and PBS was shown to be slightly more
effective than the baseline PBS for the collection of PRRSV, and could warrant further
study. Ethylene Glycol, commonly used in antifreeze, has a lower freezing point than
PBS and water and could be used where operations in cold environments were required
(Hermann, Hoff, Yoon, Burkhardt, Evans, & Zimmerman, 2006). The Hermann et al.
study was limited due to the use of PCR for quantification of sample results. Therefore,
maintenance of viable virus during sampling was not considered by Hermann.

Remel M5 Solution as a Collection Media
Most of the reviewed studies on the liquid collection of viruses used either PBS solution
or sterile water. One limitation of these collection media is that they are unable to
preserve the virus for extended time periods (Escamilla, 2009). This could be a
particularly important limitation in many military operating environments, where sample
transport over a long distance could be required for laboratory analysis. Fortunately,
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transport media is available for the extended preservation of viruses including Remel M5.
Remel M5 media has been shown to be effective at preserving virus for up to 48 hours
after specimen collection (Remel, 2005). Remel M5 has not been described in published
literature for the collection of air samples, and no literature is available to support its use
for this purpose. Liquid impingers also produce a foaming effect, especially when the
collection media contains proteins or carbohydrates. Remel M5 media contains both of
these constituents in its formulation, which could be a key limitation in selecting Remel
M5 as a collection media in impingers due to re-aerosolization of the collected virus in
the impinger. Antifoam solutions can be used to reduce this foaming effect. Six
antifoamants were evaluated for their impact on viral infectivity by Hermann and none
were shown to have a significant impact on viral infectivity. Four of the six antifoamants
did significantly affect the host cells however (Hermann, Hoff, Yoon, Burkhardt, Evans,
& Zimmerman, 2006). If further foaming reduction is required, the air flow rate into the
impinger can be reduced, although doing so could have a significant impact on sampler
performance, as discussed earlier in both the Hogan and Riemenschneider studies. Dycor
Technologies has developed a flow reducer for the XMX/2L-MIL for this purpose, but it
has not been evaluated for performance in the sampling of a viral aerosol. Therefore, it is
evident from the existing data that a virus preserving collection media, such as Remel
M5, should be evaluated for use in Air Force sampling equipment to improve the
sampling and analysis of viral aerosols, despite the inherent limitations due to the
foaming. The selection of an effective virus preserving sample media would enhance the
use of Air Force air sampling equipment in deployed environments.
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High Volume Sampling
The urgency required for field sampling in response to a suspected biological agent
release typically does not allow for the use of low volume sampling devices.
Additionally, due to the dilutive effects of an open atmosphere, sampling in response to
an outdoor release of a biological agent requires a large sample volume to better ensure
the ability to assess the potential human environmental exposure. To meet these urgent
detection and analysis requirements, high volume sampling methodologies should be
used. High volume sampling enables the collection of dilute aerosols, such as those in an
outdoor environment (Cox & Wathes, 1995). This capability comes with limitations,
however. Cox and Wathes describe these limitations in their Bioaerosols Handbook
(Cox & Wathes, 1995). Aerosol integrity can be compromised by high volume air
sampling. Use of high volume air samplers in an indoor environment “may strip the
biological particles faster than the regeneration rate.” This stripping effect of this can
result in the “misrepresentation of the bioaerosol concentration” (Cox & Wathes, 1995).
This deficiency could be very significant for sampling in a laboratory exposure chamber.
The rapid stripping of the aerosol may create particular difficulties in the evaluation of
high volume samplers using an exposure chamber with limited volume and aerosol
regeneration. Therefore it is necessary to properly monitor the aerosol concentration
during the evaluation of high volume sampling systems using a chamber.

Laboratory Studies of XMX/2L-MIL Air Sampling for Viral Aerosols
Dycor Technologies conducted an unpublished study to determine if the XMX/2L-MIL
effectively recovers aerosolized virus. These studies were conducted using a standard
41

configuration XMX/2L-MIL with PBS collection media in a 12 cubic meter exposure
chamber. This study consisted of 5 trials using MS2 bacteriophage with an airborne viral
target load of 25 agent containing particles per liter of air. Results are shown in Table 2.
The MS2 collected in this study by the XMX/2L-MIL are approximately equivalent to an
aerosol concentration measurement of 891 PFU/Liter of Air.

Trial

ACPLA

Sample Concentration (PFU/ml)

1

23.6

485000

2

23.0

445000

3

28.1

490000

4

25.3

472500

5

23.2

447500

Average

24.6

468000

Table 2: MS2 Collection with XMX/2L-MIL
(Dycor Technologies, 2009)

These results demonstrate the feasibility of using the XMX/2L-MIL to recover infectious
virus. Dycor did not evaluate multiple viral loads or decontamination of the XMX/2LMIL. Additionally, these results were collected with a single XMX/2L-MIL per trial run.
Therefore, intra-instrument variability could not be assessed using the data obtained in
this study. Published studies concerning the collection of viruses in a laboratory setting
are not available for the DFU-1000; therefore, the overall effectiveness of DFU-1000
cannot be assessed from existing literature. This data on collection of MS2 using PBS as
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the collection media, could be used as a baseline to which other sample media, such as
Remel M5, could be compared.

Field Studies using the XMX/2L-MIL for Viral Air Sampling
High volume air sampling for viral aerosols in the field has been performed with the
XMX/2L-MIL, or similar systems, in at least two separate studies. The first study
conducted in 1988 by Brenner et al. used a prototype XM2 with functions similar to the
XMX/2L-MIL (Brenner, Scarpino, & Clark, 1988). The XM2 used a combination of
virtual impaction followed by liquid impingment, and was used for air sampling during
the land application of wastewater. Brenner et al. was able to recover active
bacteriophage from the XM2 sampling media. Bacteriophage concentrations measured
by the XM2 ranged from 0 to 9 plaque forming units (PFU) per cubic meter of air
(Brenner, Scarpino, & Clark, 1988). The XMX/2L-MIL was used during an H7N3 avian
flu investigation conducted by Schofield et al. in 2005. Schofield collected samples
inside a barn where infected birds were present and in a nearby command post.
Downwind samples and random samples in the local area were collected as well. PCR
detection and semi-quantitative PCR were used for analysis. The two samples collected
inside the barn yielded positive results and relatively high estimates of viral load using
the semi-quantitative analysis (Schofield, Ho, Kournikakis, & Booth, 2005).
Additionally, live virus was extracted from these samples. The four samples collected
near the command post were found to be positive for H7N3 by PCR detection; however,
the less sensitive semi-quantitative PCR was not able to detect H7N3. The authors
concluded that these results were false positives caused by residual material associated
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with previous sample collection performed inside the barn. One sample taken downwind
in the local area was found to be positive for PCR detection, but was negative using semiquantitative PCR analysis. However, the possibility of cross contamination from other
samples was ruled out. This sample was thus considered a true positive (Schofield, Ho,
Kournikakis, & Booth, 2005). The studies by Dycor and Brenner et al demonstrate that
viable virus is capable of surviving XMX/2L-MIL collection under field sampling
conditions. The residual contamination present between samples in the Schofield study
demonstrates the need for an effective strategy to decontaminate the XMX/2L-MIL after
exposure following any sample event.

Field Studies using the DFU-1000 for Viral Air Sampling
The DFU-1000 was used in one published field study for viral air sampling. This study
conducted by Russell in 2006, involved environmental sampling for adenovirus subtype 4
in a Marine Corps training area in San Diego, California. Air samples were collected in
squad bays using both the DFU-1000 and an electrostatic precipitator. A total of 20
samples were collected with the electrostatic precipitator and 19 with the DFU-1000.
Forty-two percent of the samples collected with the DFU-1000 were positive for
adenovirus and 50 percent were positive for the electrostatic precipitator (Russell, et al.,
2006). Samples were analyzed using PCR only; although some samples were randomly
selected for viral culture analysis. Because the samples were analyzed using PCR, the
ability of the DFU-1000 to recover viable virus from field samples cannot be determined;
however, this study does demonstrate the potential for detection of virus under field
conditions using the DFU-1000. The Russell study does not provide results on the
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recovery of viable virus; therefore, the effectiveness of the DFU-1000 in a situation
where viable quantification of airborne is needed, or where confirmatory sample analysis
by culture is desired. These studies indicate that the DFU-1000 may be suitable for the
field collection of viral agents of interest and should be evaluated with other equipment
currently inventoried by the Air Force. The existing data from both field and laboratory
studies indicate that Air Force high volume air sampling equipment can be used to
recover both viable and non-viable air samples and should be comparatively evaluated to
optimize their use in the field.

Virtual Impaction
Some air sampling systems with applications to bioaerosols, such as the XMX/2L-MIL,
use a virtual impaction process to split an incoming air flow in two fractions of minor and
major flows, with the “minor flow containing larger particles above a certain cutoff size”
(Cox & Wathes, 1995). This splitting allows the production of a concentrated aliquot of
flow rich in particles relative to the ambient concentration.

Often, several of these

virtual impactors are used in a multistage series to further increase the concentration of
the particle rich airflow. Such a multistage virtual impaction system was described by
Romay in which a three stage virtual impaction system was evaluated. This system
reduced an initial flow of 300 lpm to 1 lpm, while maintaining 50 to 90 percent of the
total particle load in the desired 2.3 to 8.4 micron size range (Romay, Roberts, Marple,
Liu, & Olson, 2002). One potential disadvantage of using virtual impaction in the
collection of viral containing particles is the high efficiency at which particle sizes of 2
microns and less are eliminated from the minor flow stream. The multistage virtual
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impaction bioaerosol sampler used by Romay had a 62 percent capture efficiency for the
2.31 micron sized particles, but only a 28 percent efficiency for the 1.95 micron sized
particles (Romay, Roberts, Marple, Liu, & Olson, 2002). These results could indicate
very low particle collection efficiencies for sizes less than the 1 micrometer cutoff used in
the design of the XMX/2L-MIL. This may cause the XMX/2L-MIL to significantly
under represent a viral aerosol consisting largely of submicrometer particles. Further
laboratory analysis could confirm if these limitations are a significant contributor to the
ability of the XMX/2L-MIL to fully characterize a virus containing aerosol.

Filter Sample Collection and Extraction
Collection by filtration offers many benefits in the sampling of viral aerosols, including
greater collection efficiencies of submicron viral particles (Verreault, Moineau, &
Duchaine, 2008). An evaluation of filter performance in the collection of nano sized
particles and viruses was conducted by Burton et al. and found relatively high collection
efficiencies. Polytetrafluoroethylene (PTFE) filters with 0.3, 0.5, 1, and 3 micron pore
sizes, polycarbonate (PC) filters with 1 and 3 micron pore sizes, and gelatin filters were
simultaneously evaluated. Physical collection efficiency was evaluated using MS2 virons
and inert sodium chloride particles. For MS2 collection, the PTFE filters were all similar
in performance, with the 0.3 and 1 micron pore size filters recovering approximately
100% of the MS2 viral particles, and the 3 micron pore size filters recovering
approximately 95% (Burton, Grinshpun, & Reponen, 2007). The PC filters demonstrated
significantly lower MS2 collection efficiencies compared to the PTFE. The 1 micron PC
filter had a physical collection efficiency of approximately 70% and an approximately
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30% efficiency for the 3 micron PC filters. For inert sodium chloride particle collection,
the 0.3 micron and 3 micron sized PTFE filters demonstrated a near 100% collection
efficiency for all particle sizes in the test range of 10 to 500 nanometers. The collection
efficiency of the 1 micron PC filters ranged from 50% to 100% over the test range and
30% to 60% for the 3 micron filters (Burton, Grinshpun, & Reponen, 2007). These
collection efficiencies compare very favorably to the collection efficiencies measured by
Hogan for the AGI-30, Biosampler and the Fritted Bubbler. The physical collection for
these liquid samplers was 10% or less over the 25 to 100 nanometer particle size range
(Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005). The Burton study has
some important limitations in its application however. First, the flow rate for the filter
samplers was 4.0 lpm, therefore the data from this low volume collection may not be
applicable to the high flow rates used by the DFU-1000. Second, the data for the MS2
recovery was obtained using only real time quantitative PCR, plaque assays were not
taken to determine viral infectivity after collection. These studies show that filter
collection of viral aerosols with the DFU-1000 may be effective. A further study could
determine if the conditions produced by high volume collection negate the advantages of
filter collection shown in these studies, however.

Limitations to the Use of Filters in Air Sampling
The advantages filter collection offers in fine and ultrafine particle size collection offset
by some critical limitations. The primary limitation to the use of filters for viral air
sampling is the extraction of the sample from the filter. This extraction is typically
required for analysis, and often a large amount of sample cannot be recovered from the
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filter. In studies conducted by the Occupational Safety and Health Administration
(OSHA), a 68 percent sample removal efficiency was obtained during filter extraction
from the polyester felt DFU-1000 filters (Lawrence, 2003). A study conducted by the
United States Environmental Protection Agency (EPA) evaluated the extraction
characteristics of MS2 bacteriophage from a filter surface. Filters were seeded with
“medium” concentrations of MS2 (6.7 x 104 PFU/Filter) and high concentrations of MS2
(5.2 x 105 PFU/Filter). Extraction was accomplished by placing the seeded filter in a
tube containing PBS solution and then shaking the tube for 30 seconds, followed by 30
seconds of vortexing (EPA, 2009). For the medium seeded filters, extractions of between
21 and 52 percent of culturable MS2 were observed. The high seeded filters achieved
extraction efficiencies of around 100 percent. Although the results from these seeded
filters may not be an exact representation of MS2 in a filter after air sampling, these
results indicate that as the MS2 concentration of the filter of the DFU-1000 increases,
extraction effectiveness will also likely increase. The lower extraction efficiencies for
medium seeded filters likely limits the effectiveness of using the DFU-1000 when a low
concentration of viral agent is present.

Improvements to Filter Extraction
Methods to improve the retrieval of bioaerosol samples from a filter have been
researched as well. Burton et al. compared filter extraction methods, vortex with
ultrasonic agitation and vortex with shaker agitation, for bacterial surrogates for B.
anthracis. Both methods involved vortexing the filter and sample for 2 minutes,
followed by agitation for 15 minutes. This study found that both methods were capable
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of extracting culturable sample from the filter, but that vortex with shaker agitation
produced “significantly higher physical extraction efficiency for both mixed cellulose
ester (MCE) and polytetrafluoroethylene (PTFE) filters” (Burton, Grinshpun, & Hornung,
2005). Residual sample remaining on the DFU-1000 filter is expected to significantly
reduce the collection effectiveness of this method; however, the degree to which this
impacts the ability to accurately assess the presence and magnitude of a viral agent is
unknown.

Analytical Methods as Used in Literature
Technological developments have greatly advanced laboratory and field analytical
methods since the early studies on viral agents conducted in the 1960’s. These early
studies required active viral cultures using a variety of culture methodologies, including
inoculation into chicken embryos and plate cultures. While active viral cultures can still
provide confirmation of a positive result, and must still be used to study viral infectivity,
they are of little use in a response environment. In addition to the time requirements,
viral isolation and culture is very resource intensive, as well as requiring large amounts of
consumable supplies and laboratory support equipment along with sterile working
conditions (Fatah, Arcilesi, Chekol, Lattin, Shaffer, & Davies, 2005).

Fortunately, other

analysis methods are available today that are able to provide fast detection and
presumptive identification for viral agents to base level first responders. These methods
include immunochemical based techniques and polymerase chain reaction (PCR).
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Viable Culture Methods
In order to detect or quantify viable virus, a laboratory based culture method must be
used. The primary method of quantifying viruses is through the use of a plaque assay. A
plaque assay involves mixing a certain dilution of a virus preparation with susceptible
host cells, and spreading this mixture on a nutrient plate. After incubation, the host cells,
or bacteria in the case of plaque assay for bacteriophages, form a film on the plate with
clearings. These clearings in the film are plaques and are representative of the virus in
the sample (Adams, 1959). The number of plaques counted is directly propotional to the
number of viruses present in the sample. For bacteriophages, each plaque can “be
understood as a phage colony containing the decendants of a single phage particle”
(Adams, 1959). Every phage present in the sample will not produce a plaque; therefore,
plaque counts should be used as a relative method of quantification as opposed to an
absolute quantification (Adams, 1959). A relative quantification method is all that is
required for the comparison of air sampling equipment since the limitations to
quantification described by Adams would be present in each plaque assay conducted as
part of the comparative analysis.

Immunochemical Analysis
Immunochemical based techniques include hand held assays (HHA) and enzyme linked
immunosorbent assays (ELISA). These analysis methods provide quick turnaround times
to response personnel. HHAs are regularly employed by Bioenvironmental Engineering
and Civil Engineering Emergency Management for on scene detection. These simple
devices can be used to detect a variety of biological agents including variola (Peruski &
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Peruski, 2003). Immunochemical processes have significantly high detection limits,
however. For detection of bacterial agents, such as B. anthracis, detection limits of
approximately 10,000 colony forming units per milliliter of sample (CFU/ml) were
required (Peruski & Peruski, 2003). ELISA methods were also developed and evaluated
for the rapid detection of Ebola virus and for “Ebola like particles” by the United States
Army Medical Research Institute of Infectious Diseases (USAMRIID) in a study
conducted by Kallstrom et al. The Kallstrom study found that ELISA could be used in
the detection of Ebola virus, with detection limits of approximately 500 to 1000 plaque
forming units in an analyzed sample. Similar to PCR, ELISA does not require infectious
virus for detection. For example the Kallstrom study used an irradiated Ebola virus
sample in their analysis (Kallstrom, et al., 2005).

PCR Analysis
Although immunochemical based techniques provide a rapid detection method that is
reasonably effective, the limits of detection are still a concern for these methods. The Air
Force utilizes PCR as its presumptive detection methodology in response to a biological
agent release. PCR provides a much lower limit of detection than immunochemical
methods. For detection of B. anthracis, PCR techniques provide a limit of detection in
the range of 1 to 100 CFU/ml of sample, which is much lower than the immunochemical
limit of 10,000 CFU/ml (Peruski & Peruski, 2003). PCR allows for a small amount of
DNA in a sample to be multiplied through a series of cycles that effectively doubles the
amount of target sequence DNA per cycle. RNA viruses such as MS2 do not contain
DNA, therefore an additional step known as reverse transcriptase, is required. This
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process uses the enzyme reverse transcriptase to synthesize complementary DNA from
RNA. This synthesis process then allows the complementary DNA to be used in PCR for
detection. Real-time reverse transcriptase fluorogenic PCR was developed by O’Connell
et al. for the analysis of MS2 bacteriophage. Fluorogenic PCR uses a fluorogenic probe
that increases in florescence in the presence of the target DNA sequence (O'Connell, et
al., 2006). This florescence provides a measurable metric and a threshold of the change
in florescence is set to denote the presence of the DNA in a sample. O’Connell
developed and tested five separate primer and probe sequences for MS2 (O'Connell, et
al., 2006). For biological agent detection using the JBAIDS, sample reagents containing
these primer and probe sequences are prepared specifically for each agent of interest.
O’Connell evaluated each sample for up to 45 cycles, and results were provided as the
number of cycles required for the target sequence to reach a threshold level of detection.
There was some variation in the number of cycles required for detection based on the
probe and primer sequences used. This variation led to a change in the limit of detection.
For example, one of the five probe/primer sequences was capable of detecting 0.4
picograms (pg) of MS2 in a sample. Two of the five probe/primer sequences were
capable of detecting 4 pg of MS2 in a sample, while all five sequences were capable of
detecting 400 pg of MS2 in the sample (O'Connell, et al., 2006). This study demonstrates
the importance of properly selecting the probe/primer sequences for viral sample analysis
using PCR and the low levels of detection available in PCR analysis. The O’Connell
study also highlights some of the many difficulties in using PCR as a quantitative
analysis method, since just the selection of probe and primer sequences greatly affected
the sensitivity of the analysis.
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Limitations of PCR Analysis
A critical issue associated with any laboratory analysis method for biological agent
detection is the potential for false positives. This limitation was considered in the
selection of the JBAIDS. The acquisition testing specifications for the JBAIDS required
a false positive rate for variola of no more than 10%, or specificity of 90% (Wilson,
2006). Actual contractor validation testing of the JBAIDS obtained a specificity of 99%.
This specificity testing evaluated the ability of the JBAIDS to distinguish variola from
vaccinia, which is a closely related virus. Sensitivity requirements were also included in
the JBAIDS evaluation criteria. One pass or fail criteria for sensitivity required that the
JBAIDS be capable of identifying vaccinia virus 85% of the time. Actual operational
testing results for vaccinia obtained a sensitivity of 90.4%. Similar testing was
conducted for Ebola and Venezuelan Equine Encephalitis virus, and sensitivity of 100%
was obtained (Wilson, 2006). Some viral analysis using the JBAIDS did result in lower
sensitivities. For example, the operational testing sensitivity for Marburg was 78.5%
(Wilson, 2006), or a false negative rate of more than 1 in 5. While limited in its
application, the high levels of sensitivity and specificity allow the JBAIDS to provide a
standalone presumptive detection methodology during response to a biological agent
release. Due to the widespread use of PCR analysis and its proven capabilities, all
evaluations on Air Force biological air sampling equipment should incorporate PCR
analysis as an assessment criterion.
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Decontamination
The limited availability of air sampling equipment during a response to biological agent
release requires that effective decontamination methods and materials be available to
allow for multiple samples to be taken with a single piece of equipment. Ideally, one
decontamination methodology would be applicable to all biological air sampling
equipment. The manufacturer of the XMX/2L-MIL, recommends that removable
canister components be submerged in a 10% bleach (sodium hypochlorite) and water
solution for 5 to 10 minutes then rinsed with tap water followed by rinsing with distilled
water (Dycor Technologies, 2001). The manufacturer does not provide additional
guidance on decontamination procedures for specific microbial agents, requiring the user
to develop these procedures. As shown by Schofield et al., eliminating cross
contamination between samples collected using the XMX/2L-MIL is very important
(Schofield, Ho, Kournikakis, & Booth, 2005).

Decontaminating Agents
A variety of chemical and physical processes have been used for decontamination of air
sampling equipment. The adenovirus and meningitis study conducted by Artenstein used
a single high volume sampler, and thus required decontamination between trial runs. The
decontamination method used was a dual wash and rinse process involving a wash in a
solution of 70% alcohol and a rinse with distilled water (Artenstein, Miller, Lamson, &
Brandt, 1968). Decontamination effectiveness was not separately evaluated in the
Arttenstein et al. study. USAFSAM has evaluated decontamination procedures and
methods for the XMX/2L-MIL. These prior studies on the XMX/2L-MIL were limited to
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bacterial agents, and focused only on decontamination for the XMX/2L-MIL. These
studies used Bacillus atrophaeus, a spore forming organism commonly used as a
surrogate for Bacillus anthracis, and Bacillus subtilis as a surrogate for Yersinia pestis
(LaRoche, 2009).

The first study compared two methods of decontamination using a

10% bleach solution. The first method evaluated involved wiping the canisters of the
XMX/2L-MIL with the bleach solution, while the second method submerged the
canisters in the bleach solution. The study found that there was no statistically significant
difference between the two methods, and confirmed prior studies, which found that
hypochlorite is an effective decontaminating agent. Operator error can be a significant
factor for the wipe decontamination method however; therefore, the study recommended
that field decontamination use the submersion method (LaRoche, 2009). A second study
conducted by USAFSAM evaluated the effectiveness of three solutions for
decontamination; 5% bleach, 10% bleach, and 3% hydrogen peroxide (Lohaus, et al.,
2009). All three solutions were found to be effective for the decontamination of bacterial
agents. Decontamination by hypochorite bleach was selected by USAFSAM for further
evaluations due to its widespread commercial availability and anti-microbial
effectiveness.

Sensitivity of Viruses to Decontamination
While viral agents are less resistant to decontamination than bacterial spores and
mycobacteria, small non-enveloped viruses are still more resistant than both gramnegative and gram-positive bacteria. Large non-enveloped viruses and lipid enveloped
viruses are some of the least resistant organisms to decontamination (LaRoche, 2009).
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The relative sensitivities of different classes of microbes to decontamination is shown in
Figure 5.

Figure 5: Resistance of Microorganisms to Decontamination
(Adapted from LaRoche, 2009)

Surface Decontamination of Air Sampling Equipment
The non-expendable surfaces subject to contamination on the XMX/2L-MIL are
unpainted and painted metal, while the surfaces on the DFU-1000 are primarily plastic,
foam plastic, and coated plastic. This difference in surfaces introduces two potential
limitations to applying previous studies; the ability of the decontaminant to penetrate the
surface and the sensitivity of the material surface to corrosion and degradation from the
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decontaminant. Sodium hypochlorite is very corrosive and can impact the operation of
sensitive equipment; however, the LaRoche study noted that corrosion was unlikely to be
a significant risk to the performance of the XMX/2L-MIL (LaRoche, 2009). LaRoche
measured the presence of contamination on the surfaces of the air sampling equipment by
using cotton swabs soaked in PBS solution (LaRoche, 2009). While swabbing can be an
effective technique in identifying contamination, it has several limitations. Rose et al.
evaluated the recovery of Bacillus anthracis (BA) from a steel surface using swabs. Four
different swab materials were used, including cotton, macrofoam, polyester, and rayon.
Extraction effectiveness and the effectiveness of pre-moistening the swab prior to sample
collection were also evaluated. The authors found that macrofoam and cotton produced
the greatest recovery of BA and that pre-moistening the swab increased sample
collection. Vortexing was more effective in extracting sample from the swab than
sonication. However, recovery was still relatively low, with the cotton swabbing only
recovering 27.7 percent of the BA on the surface (Rose, Jensen, Peterson, Banerjee, &
Arduino, 2004). A follow-on study conducted using macrofoam swabs found that the
percentage of sample recovered on the swab decreased significantly when lower
concentrations of BA were present on the surface (Hodges, Rose, Peterson, Noble-Wang,
& Arduino, 2006). These lower sensitivities at low concentrations could be a significant
limitation to using surface swabs for post-decontamination evaluation when there are
very low concentrations of surface contamination. Furthermore, it is of interest to note
that the studies conducted by Rose and Hodges used BA, a spore-forming bacteria. As
shown in Figure 5, spore forming bacteria are more resistant than viruses. Therefore,
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using swabs in the evaluation of viral contamination may be even less effective than
using swabs to measure bacterial contamination.

Limitations of Previous Decontamination Studies
One key limitation to the decontamination studies conducted by USAFSAM was that
decontamination effectiveness was not evaluated for equipment reuse when using PCR
analysis methods (LaRoche, 2009). Since PCR does not require a viable organism for
detection, DNA and RNA residuals from previous sampling could result in a positive
result during PCR analysis, despite culture analysis indicating the absence of
contamination. PCR analysis using the JBAIDS system is the presumptive method of
identifying biological agents for the Air Force and should be included in all studies
involving the sampling or decontamination of biological agents.

Problem Statement and Summary
Previous literature provides a reasonably thorough background to laboratory and field
studies on the air sampling of viral aerosols. Previous studies involving the use of high
volume air sampling for viruses are more limited however.

Since these high volume

sampling methods are the primary means of response, detection, and risk assessment for
the Air Force; additional study is necessary. Experimental evaluations of the XMX/2LMIL and the DFU-1000 for the collection of viruses are not available in published
literature. Furthermore, no studies comparing performance at different levels of airborne
viral load have been performed for the XMX/2L-MIL or the DFU-1000. Evaluating air
sampling equipment at different levels of airborne viral load could provide information
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on the effectiveness of viral samplers at lower levels of detection which would be critical
in a field response. Side by side comparison of existing high volume methodologies has
also not been conducted. Simultaneous comparison of high volume sampling
methodologies and low volume sampling has also not been completed. Since low volume
collection methods such as the AGI-30 and Biosampler are widely evaluated in literature,
low volume methodologies could be considered a “gold standard” with which to compare
the XMX/2L-MIL and DFU-1000. A comparative evaluation of the XMX/2L-MIL and
the DFU-1000 would provide valuable information on the feasibility of conducting
laboratory evaluations to guide future purchase decisions of Air Force sampling
equipment for bioaerosols.

XMX/2L-MIL viral studies have been limited to PBS and water collection media.
Effectiveness of other solutions such as Remel M5 has not been evaluated for
performance in viral collection. This evaluation is necessary to determine if Remel M5
could be used for field conditions where the use of PBS and water media may not be
appropriate.

PCR detection has not been evaluated in the previous decontamination studies for the
XMX/2L-MIL. Furthermore, no decontamination studies have been completed for the
DFU-1000. USAFSAM is performing a complete decontamination evaluation on viral
agents for the XMX/2L-MIL that includes PCR analysis. Decontamination effectiveness
for viral agents should be evaluated as a comparative measure of equipment performance
for both the XMX/2L-MIL and the DFU-1000. This comparative evaluation of
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decontamination should include JBAIDS analysis to ensure that both systems are capable
of being decontaminated to a level below what the JBAIDS is capable of detecting.

In summary, a comparative evaluation on the effectiveness of Air Force high volume air
sampling equipment currently present in the inventory is necessary. This study should be
based in a controlled laboratory exposure chamber to provide stable aerosol conditions
and quantify external variables such as aerosol particle size, relative humidity, and
temperature. Equipment evaluation should include resources that would be applicable
and beneficial to a field response, such as the use of virus preserving sample media, and
detection with a field analysis tool such as the JBAIDS. This evaluation would not only
aid in equipment selection for current response use, but would also form a baseline for
future comparative studies.
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III. Methodology

Objective
This section describes the methodology used for the comparison of the XMX/2L-MIL
and DFU-1000 high volume air samplers. Procedures for the comparison of viral aerosol
sampling effectiveness and field decontamination are developed and described.

Study Design Overview
The primary means of evaluating sampling equipment for viral aerosols is through the
use of an aerosol test chamber (ATC), where aerosol concentrations and conditions can
be measured and monitored. Due to the high volumetric flow rates of air sampled by
most high volume samplers, a sufficiently large chamber must be provided. Laboratory
analysis methods, surrogate agent selection, and decontamination equipment and
methodologies must be established as well. These procedures and selection methods are
described in this section.

Surrogate Virus and Host Cell Selection
Male Specific Coliphage 2 (MS2), American Type Culture Collection (ATCC) 15597B1, was chosen as the surrogate viral agent for this study. MS2 offers several advantages
that are not offered by other agent choices. Male specific coliphages such as MS2 are
able to be controlled in the laboratory and cannot propogate in conditions outside the
laboratory. The reasons for these qualities of MS2 were described by Riemann as the
manner that MS2 attaches to and infects the E.-coli bacterium. “Male specific coliphage
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strains infect ‘male’ strains of E.-coli via the pilus.” The pilus only forms in E.-Coli at
temperatures exceeding 30 degrees Celsius, thus requiring laboratory incubation for MS2
to propogate (Riemann & Cliver, 2006). Numerous prior studies have shown that MS2
can be effectively recovered during air sampling using a variety of methodologies. MS2
is an un-enveloped, single strand RNA virus with an approximate size range of 20 to 30
nanometers. Un-enveloped viruses have been shown to have greater resistance to
decontamination and thus represent a suitable worst case for evaluation. The evaluation
of viral collection was conducted in conjunction with a decontamination study on the
XMX/2L-MIL conducted by USAFSAM, and was, therefore, the most suitable agent
available. Additionally a virus that is more resistant to environmental conditions, such as
un-enveloped viruses, is more likely to survive sampling and provide results to which
equipment comparisons can be made. Prior studies on high volume air sampling in the
laboratory setting is limited; therefore using a more resistant virus increases the
likelihood of obtaining data and being able to compare results between sampling systems.

Chamber Setup and Layout
Aerosolization studies were conducted in an aerosol test chamber (ATC) provided by
Dycor Technologies Ltd. in Edmonton, Alberta. The ATC is 12 cubic meters in volume
and approximately 3 meters in length, 2 meters wide, and 2 meters high. A layout of the
chamber is shown in Figure 6 below.
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Figure 6: Aerosol Test Chamber Layout

Three high volume ports were located approximately 1.9 meters from the point of aerosol
dispersal. A schematic showing the full layout of the ATC with component locations and
measurements of interest is available from USAFSAM. The chamber was equipped with
two circulating fans for aerosol mixing. Particle sizing was measured using a TSI
Aerodynamic Particle Sizer (APS), model number 3321. Real-time particle
concentrations were monitored and maintained using a Grimm Optical Particle Counter
model 1.108. The vent hood of the XMX was raised into the ATC to a height of
approximately 16 centimeters. The DFU-1000 was attached to a 5 cm diameter copper
pipe that was raised into the chamber to a height of approximately 16 centimeters,
consistent with the two XMX/2L-MIL samplers. Intake height was kept constant among
instruments to eliminate bias in sampling that might occur by differences in sample
collection height. The adaptation of the copper pipe to the DFU-1000 is similar in
configuration to the adaptation of the DFU-2000 assembly which allows the DFU-1000
to be used in outdoor environments. A DFU-2000 is shown in Figure 7 and consists of a
DFU-1000, a plastic housing unit, boom extension, and particle pre-separator.
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Figure 7: DFU-2000 (Left) and DFU-1000 (Right)

Low Volume Air Sampling
Two low volume air sampling methods were included in each exposure trial; the AGI-30
and the Biosampler. These low volume samplers were chosen due to their widespread
use in prior published studies and proven effectiveness in the collection of particle sizes
of 1 micron and larger. These low volume samplers can be used as a comparison
benchmark for the high volume methods. The AGI-30 and Biosampler were attached to a
stand inside the chamber near the DFU-1000 sample port and placed at a height below
the inlet points of the XMX/2L-MIL and DFU-1000. This setup is shown in Figure 8.
Air flow to the AGI-30 was provided by a vacuum line attached to the test chamber.
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Figure 8: Biosampler and AGI-30 in Aerosol Test Chamber

The Biosampler was operated using an SKC Vac-U-Go non-compensating vacuum
pump. The Vac-U-Go pump was attached to the biosampler through an apparatus that
included a water trap (Erlenmeyer flask) and field rotameter. The apparatus connected to
the Biosampler is shown in Figure 9. Low volume air sampling equipment was
calibrated before and after sampling each day using a Bios DryCal DC-2 Air Flow
Calibrator. The Bios DryCal DC-2 served as the primary flow calibrator for both the
AGI-30 and Biosampler. An SKC field rotameter was used with the biosampler as a
secondary flow standard. The AGI-30 was operated at a calibrated flow rate of 12.75 to
12.80 lpm, and the Biosampler at a calibrated flow rate of 12.5 lpm. Flow rates for the
AGI-30 and Biosampler were converted to standard liters per minute (SLPM) using
temperure and ambient pressure data. Temperature was monitored during each sample
collection period. Ambient pressure data was obtained hourly for Edmonton, AB from
the Canadian Weather Service.

65

Figure 9: Biosampler Apparatus

Aerosolization of Viral Solution
Aerosol Introduction
MS2 aerosol solution was prepared by diluting a 4.4 x 1010 plaque forming units per
milliliter (PFU/ml) stock solution with Luria broth. The MS2 stock solution was diluted
by a factor of 10 for the high and medium airborne viral loads and by a factor of 100 for
low airborne viral loads. Airborne viral loads are presented in terms of agent containing
particles per liter of air (ACPLA).

The final concentration of aerosol solution is shown

in Table 3 for each target level of viral load.

Airborne Viral

Target ACPLA

Dilution Factor

Load

Concentration of
Aerosol Solution

High

100

10

4.4 x 109

Medium

10

10

4.4 x 109

Low

1

100

4.4 x 108

Table 3: MS2 Aerosol Solution

66

MS2 solution was aerosolized using a Sonotek 8700-48MS ultrasonic atomizing nozzle,
mixed with HEPA filtered air and introduced into the chamber. The MS2 aerosol
solution was placed on an automated rocker platform (Maddell ZD-9550) and supplied to
the aerosol generator described above. The rocker and aerosol generator are shown in
Figure 10 and Figure 11. MS2 solution was supplied to the aerosol generator at a rate of
1 ml/min when additional aerosol injection was triggered by the Grimm measurements.

Figure 10: Rocker Platform

Figure 11: Aerosol Generator
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Maintenance of Viral Aerosol Concentration
Aerosol particle concentrations were monitored using a Grimm optical particle counter.
A target concentration for each level of viral load was specified by Dycor. These levels
were extrapolated using data from prior exposures conducted in the exposure chamber.
MS2 aerosol regeneration was provided via automatic injection, when the particle count
dropped below the target concentration level. Particle counting during the five minute air
purge was controlled in a similar fashion and continued until the Grimm optical particle
counter registered a sustained particle concentration of less than 1 particle (0.5 to 2.0
microns in size) per 0.12 liters of air.

Final Determination of Aerosol Concentration
Final aerosol concentration was determined using slit to agar plaque count. Two slit to
agar biological air samplers, model number STA-203 manufactured by New Brunswick
Scientific, were employed for this purpose. These slit to agar samplers operated at a flow
rate of 30 lpm. The slit to agar samplers were operated for two minutes per plate during
the high and moderate viral load trials and for five minutes per plate during the low viral
load trials and for the chamber blanks. Multiple plates were necessary during the high
and moderate viral load conditions to allow the plates to be counted after incubation.
Excessive exposure on a single plate would result in a “too numerous to count” (TNTC)
result that would invalidate the plate count.
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Equipment Preparation
Preparation of Collection Media
Remel MicroTest M5 Multi-Microbe Media (Remel M5) was selected as the collection
media for all instruments in this study. Remel M5 is commercially available in three
milliliter vials only, thus requiring multiple three ml vials to be combined in order to
produce the lot sizes required for the sampling equipment. Prior studies conducted by
USAFSAM noted excessive foaming when Remel M5 was used in an impinger collection
system due to turbulence produced in the media. This foaming was partially addressed
by the addition of 0.1% anti-foam, Y-30 aqueous emulsion, manufactured by Sigma
Aldridge, to the media. This was done after the Remel M5 had been combined into 40
milliliter lots by adding 40 microliters of anti-foam to each lot. Remel M5 with antifoam was used as the collection media for all samples, including for the preservation of
DFU-1000 sample filters. Use of similar collection media for all applications eliminated
the variability that would have been introduced by the use of multiple media types.

Preparation of XMX/2L-MIL
XMX/2L-MIL canister components were sterilized overnight in an autoclave prior to
each day of sampling. Removal of contamination was verified by swabbing each canister
prior to use. Swabs were taken around the air flow points of each canister. The canister
assembly was then inserted into the XMX/2L-MIL per manufacturer instructions. In
order to further reduce the foaming of the Remel M5 observed in prior testing, a flow
reducer was designed by Dycor for USAFSAM. This flow reducer consists of a brass
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cylinder with a small hole that is placed between the liquid impingement module and the
fluid trap to reduce secondary flow into the impinger module. This reduces airflow into
the collection media from approximately 12.5 lpm to 4 lpm and reduces the agitation and
evaporation of the collection media (Bliss, 2009).
The XMX/2L-MIL was prepared with an expendable impinger nozzle for each test per
the manufacturer’s instruction. A 50 milliliter sample collection tube was filled with 5
milliliters of Remel M5 media. This was then inserted into the XMX/2L-MIL per the
manufacturer’s instructions. The liquid impinger module of the XMX/2L-MIL is shown
in Figure 12.

Figure 12: XMX Impinger Module Shown Without Tube (Left) and With Tube (Right)

Preparation of DFU-1000
The DFU-1000 was prepared according to Air Force Technical Order 11H1-11-2 using a
standard sampling expendables kit. A new expendables kit was used for every sample
trial and includes 3 filters (1 spare), 2 pairs of latex gloves, 1 pipette, plastic whirl bags,
paraffin film, and a zip-lock bag. The kit and its contents are shown in Figure 13.
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Figure 13: DFU Sampling Kit Contents

The filter cartridges were then inserted into the intake module and attached to the pump
module and casing. The DFU-1000 filter cartridges and intake module are shown in
Figure 14.

Figure 14: DFU Filter Cartridge (Left) and Intake Module (Right)

71

Test Cycles
XMX/2L-MIL Decontamination Trials
Two test days were devoted to the evaluation of field decontamination effectiveness
following XMX/2L-MIL exposure to viral agent during sampling. Each of these sample
days consisted of an initial swabbing to verify absence of contamination, five minutes of
sampling during exposure to a purged or “clean” chamber, five minutes of sampling
under high levels of viral load, decontamination using hypochlorite solution, a 15 minute
air purge, and five minutes of sampling from a purged chamber following air purge.
Three XMX/2L-MIL high volume air samplers were simultaneously operated during
these trials. Sampling data obtained from these XMX/2L-MIL decontamination trial days
is included in this study only for evaluating response variability among multiple
XMX/2L-MIL air samplers.

Comparison Trials
Three test days were allocated to the comparison of the XMX/2L-MIL and the DFU1000. One day was allotted for studies under each level (High, Medium, and Low) of
viral load. For each sampling day, two, five minute chamber exposures to the appropriate
level of viral load were made for each high volume sampler. For each five minute
exposure period sampling using an AGI-30, and Biosampler was included as well.
Additionally, five minutes of sampling with the XMX/2L-MIL and DFU-1000 were
completed for two chamber blanks each day. Decontamination evaluation was
accomplished during these test days, as well, and is discussed in the “Decontamination
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comparison” section. A complete test matrix for the comparison trials is included in
Appendix 1.

Retrieval and Preparation of Sample
AGI-30 and SKC Biosampler
After each viral exposure run, collection media from the Biosampler and AGI-30 was
removed from the impinger assembly and transferred to a 50 ml collection tube. A final
volume of sample was measured and recorded for each sample. An example of the 50 ml
collection tubes used for all equipment throughout the study is shown in Figure 15

Figure 15: 50 ml Conical Collection Tube
(From Lawrence, 2003)

XMX/2L-MIL
Following each test run, the expendable impinger tube was discarded and the 50 ml
sample tube removed from the impinger module. Standard laboratory practices were
followed to ensure that any MS2 contamination present on the XMX/2L-MIL unit was
unable to come in contact with the sample. Once the sample tube was removed from the
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XMX/2L-MIL, it was capped, sealed with parafilm and taken to the laboratory for
analysis by plaque assay.

DFU-1000
After air sampling was complete, both dry filters were removed from the DFU-1000 filter
inserts and placed in a 50 ml collection tube with 15 ml of Remel M5 collection media.
Collection media was allowed to make complete contact with the filter material by hand
agitating the collection tube. Once received in the laboratory working area, the filters and
sample media were vortexed for 10 seconds at a speed of approximately 3200 revolutions
per minute. Sample media was then collected for analysis by plaque assay.

Laboratory Analysis
Preparation and Incubation of Plates
Differently sized plates were prepared for the plaque assay and STA collection system.
The plaque assay required 100 mm plates, while the STA required 150 mm plates for the
slit to agar. Plaque assay plates were prepared by using 10 ml of MS2 growth media with
an overlay of 200 µl of E.-coli, ATCC 15597, (8.75 x 108 CFU/ml) and 200 µl of sample,
or diluted sample, as appropriate. The overlay was mixed by gently hand swirling the
prepared plate. Slit to agar plates were prepared using 25 ml of MS2 growth media, with
500 µl of E.-coli as an overlay. This preparation technique for plaque assay plates is
described by Adams in Bacteriophages (Adams, 1959). The MS2 growth media
consisted of 5.6 grams bacto-agar, 6 grams of sodium chloride, 5 grams of proteose
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peptone, 2 grams of yeast extract, and 5.2 ml of glycerol added to 1 liter of distilled
water. After sample was added plates were incubated overnight, for a minimum of 12
hours, at a temperature of 37 degrees Celsius.

Quantification of Virus in Sample
Plaque Assay
Virus quantity was determined through the use of plaque assay. Plaque assay provides a
relative quantification of bacteriophage in a sample (Adams, 1959). Serial dilutions were
necessary for the proper quantification of these assays. This was accomplished by
vortexing the collected sample in the 50 ml collection tube to homogenize the sample.
Vortexing was accomplished using a Vortex Genie 2 manufactured by Scientific
Industries, Inc. Samples were vortexed at a speed of approximately 3200 revolutions per
minute (RPM). An aliquot of sample (50 µl) was then pipetted into 450 µl of sterile
Remel M5 media. The dilution was vortexed for five seconds to homogenize the sample
with the sterile M5 media. For further dilutions of 10-2, 10-3, and 10-4, this process was
repeated until the proper dilution had been achieved. Figure 16 shows the serial dilution
process in detail (LaRoche, 2009).

The sample plates referenced above were incubated

at least 12 hours. Plaque forming units were counted visually for each plate, as shown in
Figure 17, and the count was scaled to the proper order of magnitude by dividing the
count of plaque forming units by the dilution factor. For example, the number of plaque
forming units on a 10-3 dilution would be divided by 0.001 to obtain the final count
present in the undiluted sample. Once an approximate range of expected plaque forming
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units per ml of sample was known, a single dilution was plated as opposed to plating each
of the serial dilutions. This reduced the time, resources, and manpower required for
duplicate plating and analysis of multiple dilutions. Two plaque assay plates were
prepared for each specified dilution, as well as the undiluted samples.

Figure 16: Serial Dilution Procedure
(Adapted From LaRoche, 2009)

Figure 17: Visual Counting of Plaque Assay
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PCR Analysis
Evaluation of decontamination capabilities to levels below the limits of detection for PCR
analysis requires that samples be analyzed by PCR equipment used by Air Force
laboratory personnel during response to a biological incident. Samples were shipped to
the Applied Technology Center of USAFSAM located at Brooks City-Base, Texas for
PCR analysis. This analysis was performed for MS2 presence/absence using the JBAIDS
system. Reagents, probe, and primer sequences for MS2 are proprietary products
obtained from Idaho Technologies.

Decontamination Comparison
Selection of Swab Surfaces for Contamination Detection
Prior decontamination studies on the XMX/2L-MIL analyzed swabs taken from surfaces
directly in contact with the sample airflow (LaRoche, 2009). These surfaces are the
likely pathways for previous sampling events to contaminate succeeding samples. The
virtual impactor of the XMX/2L-MIL consists of the five components shown in Figure
18, with each having surfaces in direct contact with sample airflow.
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Figure 18: Components of XMX/2L-MIL Virtual Impaction Module
A - Primary Inlet, B - Primary Nozzle Plate, C - Upper Canister, D - Lower Canister
E - Final Nozzle (LaRoche, 2009)

Similarly, surfaces in direct contact with the sample air flow on the DFU-1000 were
selected for contamination detection. These surfaces are located on the air intake housing
and on the plastic filter inserts and are shown in Figure 19. After the surfaces were
swabbed, the swab was placed in 5 ml of Remel M5.

Figure 19: Swab Surfaces on DFU-1000
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Hypochlorite Decontamination
A decontamination solution was prepared in a 5 gallon container (shop bucket) using 1
liter of commercially available, 5.25% sodium hypochlorite bleach mixed with 9 liters of
tap water. A rinse container was prepared with 10 liters of tap water. These materials
were similar to those used in previous decontamination studies on bacterial agents
conducted by the USAFSAM (LaRoche, 2009). Each component for both the XMX/2LMIL and DFU-1000 was submerged in the container with hypochlorite solution for 5
minutes. This was followed by five minutes of submersion in the rinse container. Each
component was then hand dried using paper shop towels. Throughout the
decontamination process, separate working stations and containers were used for each
instrument. This procedure reduced the possibility of cross contamination between
instruments during the decontamination process.

Post Decontamination Swabbing
After the completion of the hypochlorite decontamination process and drying, surface
swabs were taken again using the previously described procedure. This allowed for the
quantification of residual surface contamination following decontamination. Swabs were
analyzed by vortexing for 10 seconds at approximately 3200 rpm, similar to the filter
extraction used for the DFU-1000 samples. This procedure allowed for the extraction of
MS2 from the swab into the M5 media. The collection media was then plated using the
plaque assay technique described earlier.
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Post Decontamination Air Sample Collection
To evaluate the extent that MS2 residual from previous sample runs contaminated
subsequent sample attempts, a 5 minute air sample from a purged chamber was collected
following the first MS2 exposure and field decontamination for each of the three
comparison trial days. This sampling was performed using the 2 XMX/2L-MILs and the
DFU-1000 used in the MS2 exposure and field decontamination. Samples were collected
as described in the previous sections.

Decontamination Station Ambient Air Monitoring
Results from prior studies evaluating the decontamination of bacterial agents indicated
the need to monitor for ambient air contamination in the decontamination work stations.
This is necessary since the decontamination stations at the Dycor facility are co-located
in the same room as the aerosol test chamber. This condition creates the potential for
airborne agent released during the removal of the high volume air samplers to pose a
contamination risk during portions of the decontamination processes such as drying or
surface swabbing. A single XMX/2L-MIL was operated to determine the ambient level
of MS2 contamination present in the work area. This XMX/2L-MIL was placed near the
location of the high volume air sampler test ports on the Dycor exposure chamber. This
location was considered representative of a worst case exposure to ambient MS2
contamination at the location of the decontamination stations. The decontamination
stations were located on the opposite side of the test chamber room. Undiluted plaque
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assays were prepared to analyze the samples collected from this ambient air sampling for
MS2.

Data Analysis
Calculation of Plaque Forming Units in Sample
Plaque forming units per milliliter of collection media was used to determine the air
concentration collected by the air sampling system. First the total PFU collected was
calculated by multiplying the liquid plaque concentration (PFU/ml) by the total volume
of collection media remaining after collection was complete. Use of the remaining
volume of collection media, as opposed to initial media volume, is particularly important
for impinger collection systems that tend to lose sample media during sampling. This
total PFU collection was then divided by the total air volume sampled during the five
minute trial. PFU data for the DFU-1000 and surface swabs were similarly determined,
except that the volume of media added to the collection swab or filter was the volume
used as the total media volume.

Particle Size Distribution Analysis
To determine the extent that the particle size distribution had as a performance factor in
the effectiveness of the sampling systems, particle size distributions were analyzed for
similarity using their Count Median Diameter (CMD). A CMD distribution of 51 six
second Grimm samples was prepared for each trial. Comparison of CMD distributions
between trials was conducted using a Kruskal-Wallis one way ANOVA (K-W ANOVA),
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with a Dunn’s rank sum post-test when significant differences were identified by the KW ANOVA. Non-parametric comparisons of the median were needed once it was
determined that an assumption of normality or log-normality could not be made. This
determination was made using results from the Kolmogorov-Smirnov test for normality.
Additionally, non-parametric analysis methods, such as K-W ANOVA, are considered to
provide a more conservative analysis of variance. Kruskal-Wallis and KolmogorovSmirnov analysis was performed using Minitab version 15. The Dunn post-test analysis
was performed using Prism Graphpad software, version 5.

MS2 Sample Data Analysis
The small number of samples taken for both the air sampling and decontamination
comparisons do not allow for the reliable use of parametric statistics for data analysis.
For a small data set, a determination of normality cannot be made or assumed.
Additionally a comparison of means is more likely to be influenced by the presence of
outlying data points. For these reasons, the non-parametric K-W ANOVA was used for
the analysis of these results as well. The Dunn post test was conducted once the K-W
ANOVA identified significant differences between data sets.
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IV. Results and Analysis

Air Sampler Flow Rate
Flow rate measurements for the XMX/2L-MIL were conducted by Dycor Technologies
using a proprietary method. Measurements were made at the exhaust point of each
instrument after three minutes of operation and 20 minutes of operation. The results for
the measurements taken after three minutes of operation are presented in Table 4. Each
sample presented in this study was collected for five minutes; therefore, the air flow rate
at three minutes is considered to be a representative average air flow rate during the five
minutes of sample collection.

Instrument

Temperature
(Celsius)

Pressure (kPa)

Flow Velocity
(m/s)

Flow (slpm)

XMX 1

46.4

93.49

6.60

667

XMX 2

42.6

93.43

6.15

620

XMX 3

44.6

93.42

6.15

620

XMX 4

43.3

93.42

5.94

599

DFU

28.3

93.90

7.67

778

Table 4: High Volume Equipment Flow Rate Measurements
Provided by Dycor Technologies, 2009

The measurements provided by Dycor were calculated using a proprietary methodology
and presented as flow rate in standard liters per minute (SLPM) or air flow at 25 degrees
Celsius and 101.325 kilopascals (kPa). These flow rates were then converted to liters per
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minute using ambient temperature and pressure conditions. The ambient flow rates for
each trial are presented in Appendix 4. Flow rates measured after three minutes of
operation are used in the remainder of the data analysis. These ambient flow rates are
considered to be the most representative measurement of the actual air flow through the
high volume sampler. This conversion allows for sample data from the high volume air
samplers to be compared with data obtained from the low volume air sampling equipment
on a standardized unit of volume (1 liter) basis. Flow rates calculated using the Dry-Cal
for the AGI-30 and SKC Biosampler are presented in Table 5. These flow rate
measurements were confirmed before and after each day of air sampling. Both the AGI30 and Biosampler act as a critical orifice, thus maintaining constant flow during
sampling.

Instrument

Ambient Flow Rate (lpm)

Pump Method Used

AGI-30

12.75

Vacuum Line

Biosampler

12.5

Vac-U-Go Sonic Flow
Pump

Table 5: Low Volume Equipment Flow Rate Measurements

Particle Analysis of Viral Aerosol in Chamber
Particle Loading in Chamber
Particle loading in the chamber was measured by the Grimm Optical Particle Counter and
was observed to vary widely throughout the five minutes for each trial run. An example
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of particle loading variation is shown in Figure 20 below. Figure 20 shows a time
elapsed plot of the particle count present in the chamber using 18 second moving
averages collected from the Grimm OPC.

Figure 20: Particle Load in Chamber as a Function of Time, Trial 06

The results shown in Figure 20 are representative of the variation observed for all trials in
the particle loading throughout each trial. A significant drop in aerosol particle
concentration in the chamber was frequently observed after the air sampling equipment
began operating for the majority of trials. This drop in particle concentration
demonstrates the tendency of high volume air sampling equipment to strip particles from
the aerosol faster than they can be regenerated. Chamber particle concentration plots for
all sample trials are included in Appendix 3
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Overall Particle Size Distribution during Sample Runs
Particle size distributions (as dN/dLogDp) for both high and low ACPLA sample runs are
shown in Figure 21 and Figure 22. These figures are presented as examples of the
particle size data recorded by each instrument during an air sampling trial. Geometric
mean particle size for each trial run is shown in Table 6. Geometric mean particle size
and count median diameter (CMD) are the same for lognormal particle size distributions.
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Figure 21: Particle Size Distributions for Example High ACPLA Trial 06, ACPLA = 93.2
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Figure 22: Particle Size Distributions for Example Low ACPLA Trial 18, ACPLA = 9.3

As shown by both the visual comparison of the particle size distribution plots and by
comparison of the geometric mean particle size, there is a substantial difference in the
particle size data reported by the APS 3321 and the Grimm OPC. This requires that the
most representative size distribution be selected for further analysis and comparison.
Particle size distributions plotted using data from the Grimm OPC tend to represent
smaller particle sizes more than particle size distributions plotted using APS data. The
most likely reason for this difference is the particle size sorting limit for each instrument.
The Grimm OPC has a lower particle size sorting limit of approximately 0.3 microns,
while the APS has a lower sorting limit of approximately 0.5 microns. For this reason,
the Grimm OPC is considered to be the most representative instrument for the evaluation
of particle size distribution and further analysis will be limited to data obtained from the
Grimm OPC.
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93.2

APS 3321 Geometric
Mean Diameter
(Microns)
3.588

Grimm OPC
Geometric Mean
Diameter (Microns)
1.410

TR 09

74.4

3.376

1.227

TR 18

13.9

1.420

0.489

TR 21

21.0

2.264

0.588

TR 25

9.3

N/Aa

0.642

TR 28

18.4

2.513

0.624

Trial

ACPLA

TR 06

a

Particle size distribution for trial run not collected due to equipment error
Table 6: Comparison of Geometric Mean Diameter From APS 3321 and Grimm OPC

Comparison of Particle Size Distribution Between Sample Runs
Count median diameter (CMD) was calculated for each 6-second particle size distribution
measured using the Grimm optical particle counter. Particle size distributions between
sample trial runs were compared using a Kruskal-Wallis one way ANOVA of the count
median diameters for each 6 second sample. Six second CMDs for each trial run are
presented as a in Figure 23 below.
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Figure 23: Six Second Count Median Diameter (CMD) Measured by Trial Run

Comparison of particle size between sample runs using a Kruskal-Wallis one-way
ANOVA (α = 0.05) revealed a significant difference (P < 0.001) in the median CMDs
between the 6 trial runs. A Dunn’s rank sum post test identified that the high ACPLA
median CMDs were significantly different from the low ACPLA median CMDs. No
other significant differences, such as CMDs within high ACPLA or within low ACPLA
trials, were identified. Median CMD for each trial is shown in Table 7.
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Trial

ACPLA
93.2

Median CMD
(Microns)
1.60

Range of CMD
(Microns)
0.35 – 5.43

TR 06
TR 09

74.4

1.30

0.35 – 5.76

TR 18

13.9

0.40

0.35 – 1.16

TR 21

21.0

0.45

0.00a – 3.01

TR 25

9.3

0.40

0.00a – 2.67

TR 28

18.4

0.38

0.00a – 4.06

a

Numerous six second samples taken with the Grimm OPC failed to detect particles, therefore a 0.00 CMD
was used for statistical representation.
Table 7: Comparison of CMD Between Trials

Comparison of Air Sampling Equipment in the Collection of MS2 Aerosol:
Performance Comparison of MS2 Collection for all Evaluated Air Sampling Equipment
Overall results for the collection of aerosolized MS2 bacteriophage as a function of viral
load present in the chamber are shown in Figure 24. Viral load in the chamber is
expressed in terms of agent containing particles per liter of air (ACPLA).
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Figure 24: MS2 Air Sample Collection Relative to ACPLA Present in Chamber

As indicated by the results shown in Figure 24, the XMX/2L-MIL was shown to be as
effective as both low volume air samplers to which it was compared. A large degree of
intra-instrument variability was observed in the XMX at high ACPLA levels. The DFU1000 appears to have similar MS2 collection performance to the other evaluated air
samplers when high ACPLA levels are present. At lower ACPLA levels, the DFU-1000
appears to underperform the XMX/2L-MIL, AGI-30, and Biosampler on a concentration
basis.
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Several data points are excluded from these presentations including 1 data-point for the
DFU-1000, 2 data-points for the AGI-30, 2 data-points for the Biosampler, and 1 datapoint from each XMX unit. Upon initial evaluation of the data from the plaque assays, it
was apparent that serial dilutions were probably mis-recorded either during the plating
itself or when the plates were being counted and data assigned to a particular dilution.
This probable error may have resulted in a shift in the plaque count of an order of
magnitude from the actual plaque count had the plates been accurately recorded. A plot
incorporating all data points is included in Appendix 7, Figure 33. Plots containing all
data points corrected to the serial dilution that the author considers to be correct are
included in Appendix 9.

Air sample results were standardized by the viral load (ACPLA) present in the exposure
chamber to PFU/liter of air per ACPLA. This standardization allows for a median MS2
air sample concentration to be determined using data collected from multiple levels of
airborne viral load present in the chamber. Standardized results are presented in Figure
25.
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Figure 25: Air Sample Results Standardized to 1 ACPLA of Viral Load

The median results and range for each instrument are presented in Table 8. The reduced
MS2 collection by the DFU-1000 at lower ACPLA levels significantly decreases the
median standardized MS2 concentration measured by for the DFU-1000 as shown in
Table 8.

XMX 2

Median Sampled MS2
Concentration per ACPLA
Present in Chamber
PFU/(Liter Air*ACPLA)
43.98

Range of Sampled
Concentration per ACPLA
Present in Chamber
PFU/(Liter Air*ACPLA)
34.33 – 52.50

5

XMX 3

54.89

21.51 – 79.57

5

DFU

10.19

2.55 – 31.12

4

AGI-30

29.39

26.44 – 50.43

4

Biosampler

30.29

22.78 – 37.14

Number of
Trials

Instrument

5

Table 8: MS2 Collection by Instrument Standardized to 1 ACPLA of Viral Load
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Comparative analysis between all evaluated samplers using Kruskal-Wallis one way
ANOVA (α = 0.05) revealed a significant difference (p = 0.009) in the median
standardized MS2 collection. A Dunn’s rank sum post test revealed that the standardized
MS2 collection obtained using the DFU-1000 is significantly different from the MS2
collection obtained using the XMX/2L-MIL. This significant difference was found for
both XMX 2 and XMX 3. Other comparison results using the Dunn’s post-test reveal no
significant difference between the XMX/2L-MIL, the AGI-30, or the Biosampler or
between the DFU-1000 and the AGI-30 or Biosampler. Kruskal-Wallis one way
ANOVA results were also performed on the corrected data-set in Appendix 9 and
confirm the findings of the data analysis presented with the data points excluded.

Quantification Limitations of Air Sampling Instruments
Low levels of airborne viral load, less than 5 ACPLA, were not successfully produced
during any of the six trials. The lowest level of viral load produced was 9.3 ACPLA.
Plots of MS2 sample collection relative to ACPLA present in chamber for the high
volume air samplers with linear trendlines are included in Figure 26. As indicated by the
linear trendline, the DFU-1000 is unable to reliably deliver quantifiable results at ACPLA
levels lower than approximately 14 ACPLA. MS2 collection using the XMX/2L-MIL
suggests a possible linear relationship relative to ACPLA present in the chamber. This
allows the XMX to reliably produce quantifiable results for MS2 collection at the levels
of airborne viral load evaluated in this project. The similarity of the linear trendlines for
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XMX 2 and XMX 3 appear to be caused by chance. A high degree of variability was
observed between XMX 2 and XMX 3.

DFU
Linear (DFU)
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DFU Linear Fit Eqn.
y = 32.255x - 447.17
R2 = 0.9455
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XMX 2 Linear Fit Eqn.
y = 39.267x + 174.46
R2 = 0.8929
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XMX 3 Linear Fit Eqn.
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R2 = 0.713
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Figure 26: MS2 Collection by High Volume Air Sampling Equipment with Linear Trendlines

MS2 sample collection trendlines for low volume sampling equipment are shown in
Figure 27. Similar to the XMX/2L-MIL, the AGI-30 and Biosampler produce reliable
results at all trial ACPLA levels. This indicates that quantifiable measurements of
airborne viral load can be obtained using the AGI-30 and Biosampler at the levels of
airborne MS2 evaluated in the trials presented in this study.
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Figure 27: MS2 Collection by Low Volume Air Sampling Equipment with Linear Trendlines

PCR Results from Air Sampling
PCR results for the air sampling are shown in Table 9. All high volume air sampling
systems were capable of collecting a sample resulting in PCR detection for MS2. XMX 2
produced one false negative PCR result and one inconclusive result during a trial with a
very high MS2 plaque assay count. While the Biosampler and AGI-30 were capable of
collecting an MS2 sample above the detection limits of the JBAIDS in a majority of
trials, as expected, the low flow rates result in difficulty collecting sufficient MS2 for a
relatively high proportion of the samples. This effect was particularly pronounced with
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the Biosampler, where only 60 percent of samples resulted in a detection of the presence
of MS2. PCR analysis includes one replicate per sample. An inconclusive result occurs
in the event of difference between the primary analysis and the replicate. An absent
result occurs when the detection threshold is not reached after a large number of PCR
cycles. The number of cycles is typically established by the manufacturer, with 45 cycles
being the typical value used for the JBAIDS. Raw results from the PCR analysis,
including the number of cycles required to reach the detection threshold, is included in
Appendix 2, Table 25.

Instrument
XMX 2

Number of Trials with PCR
Analysis
6

JBAIDS-PCR Result for MS2 (#
Present/#Absent/#Inconclusive)
4/1/1

XMX 3

6

6/0/0

DFU

6

6/0/0

AGI-30

5

4/0/1

Biosampler

5

3/2/0

Table 9: JBAIDS PCR Results for Sample Analysis Following Exposure to MS2

Intra-instrument Variability for the XMX
Results for the trials that collected MS2 using 3 XMX/2L-MIL samplers only are
presented in Table 10. These results also indicate a large degree of variation between
multiple XMX/2L-MIL operating in high viral load conditions and confirm the large
intra-instrument variability found during trials TR06 and TR09.
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8109

MS2
Concentration
XMX 2
(PFU/Liter of Air)
9597

MS2
Concentration
From XMX 3
(PFU/Liter of Air)
18879

3274

3311

2282

Trial

ACPLA

MS2 Concentration XMX 1
(PFU/Liter of Air)

TR 3

80.8

TR 13

82.2

Table 10: MS2 Concentration Sampled during High ACPLA XMX/2L-MIL Decontamination Trials

Comparison of MS2 Collection by XMX Apparatus and Sample Media
A previous study conducted by Dycor Technologies collected MS2 bacteriophage using
an unmodified XMX/2L-MIL with phosphate buffered saline collection media. As
previously described, the XMX/2L-MIL systems employed in the current study were
modified by reducing the air flow to the impinger and by using Remel M5 media instead
of phosphate buffer solution. In the previously conducted study by Dycor, five samples
were collected using a single XMX/2L-MIL over a relatively narrow viral chamber load
range of 23.0 to 28.1 ACPLA. The results from this study in PFU/liter of air were
standardized PFU/liter of air per ACPLA present in the chamber. This allows for
comparison with the results from the current study. The side by side comparison of the
two studies is shown in Table 11.
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Instrument

XMX Dycor (12.5
lpm secondary
flow and PBS
Collection Media)
XMX SAM
(Secondary Flow
Reduction and
Remel M5
Collection Media)

Number of
Trials

Median Sampled MS2
Concentration per ACPLA
Present in Chamber
PFU/(Liter Air*ACPLA)

Range of Sampled
Concentration per
ACPLA Present in
Chamber
PFU/(Liter Air*ACPLA)

5

36.30

32.90 – 38.78

10

56.55

37.21 – 79.57

Table 11: Comparison of XMX/2L-MIL using PBS Media and No Secondary Flow Reduction (XMX
Dycor MS2 Study) with XMX/2L-MIL using Remel M5 Media and Secondary Flow Reduction

Data analysis using a Kruskal-Wallis one-way ANOVA (α = 0.05) revealed a significant
difference (p = 0.027) in the MS2 collection effectiveness between the two XMX
operating methodologies. Full results from this Kruskal-Wallis one-way ANOVA are
included in Appendix 6. These results indicate a significant difference between the two
sampling apparatuses, but are not able to identify the factors responsible for the
difference. Either of the two modifications, or the combination of modifications, could
have been responsible for the differences in viral collection observed between the two
studies.

Decontamination Comparison of Air Sampling Equipment
Decontamination effectiveness for the XMX/2L-MIL and DFU-1000 was evaluated by
comparing sample results to initial background results and by comparing the degree that
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contamination was reduced when field decontamination is performed on the XMX/2LMIL and DFU-1000.

Comparision of Equipment Field Decontamination Between Air Samples
As shown in Table 12, residual contamination remaining in air samples taken from a
purged chamber after decontamination was significantly reduced to levels comparable
with the initial background levels in the chamber before MS2 was introduced. The
residual contamination level detected in the post decontamination was compared to the
initial background level in the chamber using a Kruskal-Wallis one-way ANOVA (α =
0.05) and found not to be significantly different for XMX unit 2 (p = 0.268), XMX Unit 3
(p = 0.077), or the DFU (p = 0.275). Full results from this ANOVA analysis are included
in Appendix 6. The analysis presented here is limited by the small number of trials (n=3)
with which the comparisons are made.

Instrument
XMX 2

Post Decontamination
Initial Background Median MS2
Median MS2 Concentration
Concentration (PFU/Liter of Air)
(PFU/Liter of Air)
0.000
0.019

XMX 3

0.004

0.067

DFU

0.027

0.009

Table 12: MS2 Air Sample Concentrations Measured using the XMX/2L-MIL and DFU-1000 before
Exposure (Background) and after Decontamination
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Median reduction for contamination between sampling events is presented in Table 13
below. Raw data for each trial is included in Appendix 5. A minimum reduction of
99.9% in MS2 was achieved for each sample run and for all evaluated equipment.
Percent reduction is obtained by comparing the sample result collected from exposure to
MS2 in the chamber to the result obtained after sampling in an air purged chamber with
the decontaminated instrument.

Instrument
XMX 2

Number of
Trials
3

Median Reduction in MS2
Contamination %
99.994

Range of Reduction in
MS2 Contamination %
99.935 - 99.999

XMX 3

3

99.999

99.983 - 99.999

DFU

3

99.999

99.996 – 100.000

Table 13: Reduction in MS2 Contamination between Air Samples Measured by Plaque Assay

Raw data, including results from the plaque assay, from which the mean reduction was
generated is included in Appendix 5. Analysis conducted with a Kruskal-Wallis
ANOVA (α = 0.05) established no significant difference (p = 0.304) in the median
reduction of MS2 decontamination obtained from the two XMX/2L-MIL and the DFU1000 indicating that both instruments can be sufficiently decontaminated with
hypochlorite bleach. The results from this Kruskal-Wallis ANOVA are shown in
Appendix 6. PCR results for analysis with the JBAIDS are presented in Table 14.
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3

Post-Exposure Sample JBAIDS
Results
#Present/#Absent/#Inconclusive
3/0/0

Post-Decontamination Sample
JBAIDS Results
#Present/#Absent/#Inconclusive
0/2/1

XMX 3

3

3/0/0

0/3/0

DFU

3

3/0/0

0/3/0

Instrument

Number
of Trials

XMX 2

Table 14: Evaluation of MS2 Contamination between Air Samples by JBAIDS-PCR Analysis

Effective reduction of residual contamination between air samples to levels below the
detection limits of the JBAIDS was observed for both the DFU-1000 and XMX/2L-MIL.
One post-decontamination sample was inconclusive for the presence of MS2.

Comparison of Surface Removal of Decontamination
Mean reduction in surface contamination is shown in Table 15, with data for individual
trials included in Appendix 5. The mean reduction in surface decontamination for the
DFU-1000 was very similar to the mean reductions observed for the XMX/2L-MIL.
Analysis using Kruskal-Wallis one-way ANOVA (α = 0.05) revealed no significant
difference (p = 0.209) between the DFU-1000 and XMX/2L-MIL in mean reduction of
MS2 surface contamination after decontamination with hypochlorite. The range of
values for mean reduction in surface contamination for the DFU-1000 is slightly higher
than reductions observed in the XMX/2L-MIL, however.
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Instrument

Number of
Trials

Median Reduction in
MS2 Contamination %

Range of
Decontamination %

XMX 2

5

99.589

99.091 - 99.966

XMX 3

5

99.615

99.583 - 99.999

DFU

4

99.702

97.753 – 99.711

Table 15: Reduction in Surface Contamination Measured by Plaque Assay

Similar to the results obtained in the evaluation of residual contamination between air
samples, surface decontamination was also reduced to a level below the JBAIDS limit of
detection. These results are shown in Table 16 below. Pre-decontamination detection of
surface MS2 contamination was shown to be inconsistent with several samples showing
absence for MS2 or inconclusive results. Possible explanations for these false negative
results are explained in the discussion section. All samples and duplicates for postdecontamination samples were found to be absent of surface contamination with MS2.
Complete laboratory results from the JBAIDS-PCR analysis, including cycles required to
reach detection threshold, are included in Appendix 2, Table 25.

6

Post-Exposure Surface Sample
JBAIDS Result
#Present/#Absent/#Inconclusive
4/2/0

Post-Decontamination Surface
Sample JBAIDS Result
#Present/#Absent/#Inconclusive
0/6/0

XMX 3

6

5/0/1

0/6/0

DFU

5

2/2/1

0/5/0

Instrument

Number
of Trials

XMX 2

Table 16: Evaluation of Surface Contamination by JBAIDS-PCR Analysis
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Background Contamination in Work Area
Results for the XMX/2L-MIL air samples taken in the decontamination work area are
included as a daily average in Table 17. Four 30 minute samples were collected each day
during the time periods in which the equipment was removed from the chamber,
decontaminated, swabbed, and prepared for the next sample being collected. A single
spike in the number of plaque forming units was noted in the final sample taken on 30
July 2009. As with the air samples collected inside the exposure chamber, results are
reported as PFU/Liter of Air and as a daily average.

Date

Mean MS Air Concentration in
Work Area (PFU/Liter of Air)

28 July 09

0.008

Range of MS Air
Concentration in Work
Area (PFU/Liter of Air)
0.006 – 0.009

30 July 09

0.021

0.003 – 0.058

31 July 09

0.006

0.004 – 0.009

Table 17: MS2 Air Sample Concentration in Work Area

The airborne concentration of MS2 in the work area was very low. These results from
the plaque assay are also supported by PCR analysis of the work area samples. Of the 12
samples collected in the work area and analyzed by JBAIDS-PCR, 11 failed to detect the
presence of MS2 and one sample was inconclusive for the presence of MS2. The
inconclusive sample was taken on 30 July 2009 and corresponded to the highest sample
concentration detected by plaque assay out of the 12 samples taken in work area. Based
on these results, some contamination could have potentially entered the work area from
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the chamber on 30 Jul 2009; however, any impact on post-decontamination sample
results appears to be negligible.
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V. Discussion and Conclusions

Discussion Overview
This thesis comparatively evaluated the performance of currently inventoried high
volume air sampling equipment in response to a surrogate viral agent, MS2
bacteriophage. Criteria evaluated included overall effectiveness of virus recovery over a
range of airborne agent concentrations and the decontamination characteristics of the
equipment using methods available during fielded operations. Overall limitations of this
research included: the inability to achieve low agent concentrations representative of
minimally infectious doses, the relatively small number of samples collected, the limited
variation of environmental conditions evaluated, and the inherent limitations in the use of
a surrogate viral agent.

Aerosolized MS2 Collection by Instrument
Comparison of MS2 Collection by High Volume Collection Systems
This study demonstrated that the XMX/2L-MIL was capable of significantly (p = 0.009)
greater collection of MS2 than the DFU-1000 under the sampling conditions evaluated
for low ACPLA conditions. The collection of MS2 bacteriophage by the XMX/2L-MIL
was also statistically similar to the AGI-30 and SKC Biosampler. Previous studies, such
as the Indian smallpox study during the 1960’s conducted by Downie, demonstrated that
methods employing dry media recovered less viable virus than liquid collection methods
(Downie, 1965). Tseng et al. also demonstrated significantly higher relative recoveries of
aerosolized MS2 using a liquid collection method, the AGI-30, than the relative recovery
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obtained using dry nuclepore filters (Tseng & Li, 2005). Therefore, it was not surprising
that the overall collection was significantly less for high volume sampling methods
employing dry media than high volume methods employing liquid collection. One
interesting finding in this study was the large variation in collection effectiveness of the
DFU-1000 relative to different levels of MS2 concentration in the chamber. The DFU1000, on a per unit of air volume basis, demonstrated similar viable collection
performance at higher ACPLA to the XMX/2L-MIL. At lower ACPLA, the DFU-1000
significantly underperformed compared to the XMX/2L-MIL. This finding demonstrates
the potential that recovery of viable viral agent from dry media is more limited by the
separation of the collected agent from the media than from the actual maintenance of
viable agent on the filter during sampling. These suggestions are discussed further in
other areas of this section. Relatively low air concentration levels would be expected
during a response to a viral agent and this study demonstrates that the XMX/2L-MIL
would likely outperform the DFU-1000 under such conditions. The linear regression of
the plaque assay results for the MS2 collected by the DFU-1000 suggests that MS2
concentrations could not reliably be quantified at levels below 14 ACPLA. The
XMX/2L-MIL and the DFU-1000 both recovered detectable quantities of viable MS2
bacteriophage at all evaluated concentrations of MS2 containing particles. This was
further confirmed by the JBAIDS-PCR analysis of the collected samples, which mostly
reported detectable results for MS2 samples taken during the trials. Interestingly, one of
the XMX/2L-MIL systems, XMX 2, produced one sample that failed to detect MS2 and
one inconclusive sample for MS2 when analyzed with the JBAIDS-PCR. These results
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occurred despite very high viable MS2 concentrations for these samples when analyzed
using plaque assay. This non-detect result would be considered a false negative result for
the JBAIDS-PCR analysis and there are several explanations for this occurrence. First,
as stated earlier, the JBAIDS analysis was performed at Brooks City Base, Texas, which
required significant transit times. These transit times were particularly long, up to 16
days, from the time that the samples were actually collected. The effect that these longer
hold times would have had on the integrity of viral RNA in the sample is not known.
Second, the sensitivity of the JBAIDS, as reported by Wilson varies among different viral
agents with some viral agents having sensitivities as low as 78.5 percent. The sensitivity
of the JBAIDS for non-pathogenic surrogates, such as MS2 is unknown, but this could
explain the occurrence of a false negative like that observed here. Third, technical error
during laboratory analysis could also result in a false negative. For example, during
analysis the technician may have failed to place the extracted RNA into the capillary tube
for analysis (Escamilla, 2009). Although a technical error such as this would be rare,
such an error could nonetheless explain a false negative in both the primary and duplicate
sample. Technical laboratory errors, such as those mentioned above, could indicate the
need to take duplicate air samples for each area during a response. Collecting and
analyzing duplicate samples would increase confidence that a negative result obtained
from the laboratory is truly a negative result.
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Comparison of High Volume Liquid Collection to Low Volume Liquid Collection
This study demonstrated similar collection performance between the XMX/2L-MIL high
volume liquid collection method and both of the low volume liquid collection methods.
However, several limitations in applying the results of the AGI-30 for MS2 collection
must be noted in this discussion that could have underrepresented the reported results.
First, during the analysis of the AGI-30 samples, serial dilutions were only performed to
a factor of 10-1. This resulted in a plate count that was TNTC for one of the samples, trial
run 06, taken during a high ACPLA trial. Results were reported in the data analysis at
the minimum threshold at which a TNTC result is obtained. These results could
significantly underestimate the actual collection of MS2 by the AGI-30. Secondly, the
excessive foaming by the Remel M5 collection media resulted in a significant loss of
sample during collection. Including a liquid trap, similar to the Erlenmeyer flask used for
the Biosampler apparatus, between the sampler and the hose could have prevented this
problem. Since a trap was not included in the AGI-30 apparatus, there was no way to
prevent sample loss, and MS2 collection by the AGI-30 may be underreported as a result.
The XMX/2L-MIL demonstrated a large degree of variability between the two
instruments at high MS2 containing particle concentrations. This large degree of
variability was also confirmed during the trials in which three XMX/2L-MIL systems
were exposed to a high concentration of MS2 containing particles for the purposes of
evaluating viral decontamination methods. Variability between different XMX/2L-MIL
systems was also noted by LaRoche during trials involving collection of bacterial agents.
This large degree of variability could be a significant limitation if the XMX/2L-MIL
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were used in a situation where quantification of high concentrations of viral agent was the
goal. LaRoche also attributed observed XMX/2L-MIL variation to inconsistent mixing
within the exposure chamber. Since the same exposure chamber used by LaRoche was
used for this study, similar mixing inconsistencies may have occurred in these trials as
well. High concentrations such as those created during the high agent concentration trials
are very unlikely during a response to an environmental release of a viral agent or as a
consequence from a natural disease outbreak. Intra-instrument variability cannot be
assessed for the DFU-1000, AGI-30, or Biosampler since multiple samplers were only
included in this study for the XMX/2L-MIL. Variability may have an important impact
on the performance of these other sampling systems as well. Future studies should
include multiple simultaneous trials of all equipment being evaluated to fully consider the
effect of intra-instrument variability on system performance.

Factors Impacting Air Sampling Performance
The particle size analysis between the high particle concentration trials and the low
particle concentration trials revealed a significant difference in the count median diameter
of the MS2 test aerosols. Each air sampling system has a specific collection efficiency
that varies by particle size. As shown in chapter two, detailed information on collection
efficiency is available for the XMX/2L-MIL, the AGI-30, and the Biosampler. Only
limited information was available for the DFU-1000. Collection efficiencies for the AGI30 and Biosampler were extrapolated using data from a study conducted by Willeke
comparing the capture efficiencies of low volume air sampling methods (Willeke,
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Xuejun, & Grinshpun, 1998). Table 18 and Table 19 show theoretical particle capture
for the XMX/2L-MIL, AGI-30, and Biosampler for high and low ACPLA trials. The
example trials used in this comparison are TR06 for the high ACPLA run and TR18 for
the low ACPLA run. These theoretical particle capture tables were generated using
particle size distributions measured by the Grimm optical particle counter for the entire
trial period of 5 minutes and reflect the particles counted from a 6 liter aggregate sample.

Particle

Total Particles in

Size Range

Size Range

(Microns)

(#Particles/Liter)

XMX/2L-MIL

Biosampler

AGI-30

Theoretical

Theoretical

Theoretical

Particle Collection

Particle Collection

Particle Collection

(# Particles/Liter)

(# Particles/Liter)

(# Particles/Liter)

0.3 – 2.0

960

134

844

745

2.0 – 4.0

383

280

365

364

4.0 – 7.5

334

234

316

316

7.5 - 20

8

2

7

7

Total

1685

650

1532

1432

Table 18: Theoretical Particle Collection by Sampling System for High ACPLA Trial
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AGI-30
Particle

XMX/2L-MIL

Biosampler

Theoretical

Theoretical

Particle Collection

Particle Collection

(# Particles/Liter)

(# Particles/Liter)

Total Particles in

Size Range
(Microns)

Theoretical
Particle

Size Range

Collection (#

(#Particles/Liter)

Particles/Liter)
0.3 – 2.0

793

41

659

568

2.0 – 4.0

42

30

41

40

4.0 – 7.5

10

6

10

10

7.5 - 20

0

0

0

0

Total

845

77

710

618

Table 19: Theoretical Collection by Sampling System for Low ACPLA Trial

More detailed information on the XMX/2L-MIL particle collection efficiency for the
high and low ACPLA trials is available through the USAFSAM. XMX/2L-MIL
collection efficiency for particles less than 1 micron in size was not available. The
theoretical particle capture presented in Table 18 and Table 19, assumes a low collection
efficiency of 3 percent for these small particles. As discussed in chapter two, the AGI-30
and Biosampler have superior particle size capture efficiencies when compared with the
XMX/2L-MIL for all particle sizes up to 20 micrometers. These collection efficiencies
and the theoretical particle captures shown in Table 18 and Table 19 indicate that the
XMX/2L-MIL would be expected to have significantly lower collection performance if
particle capture is the primary contributing factor to viable virus recovery. The capture
efficiencies used for Table 18 and Table 19 were determined using an unmodified
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XMX/2L-MIL with either phosphate buffered solution or sterile water as the collection
media. The modifications made to the XMX/2L-MIL for viral collection in this study
included lowering the flow rate into the liquid impinger and the use of Remel M5 media.
As discussed, flow rates into the impinger were reduced from approximately 12.5 lpm to
approximately 4 lpm. Previous studies conducted by Hogan, as discussed in chapter two,
address the effect of flow reduction on impinger collection efficiency. These studies
indicate that significantly lowering the air flow rate into the impinger significantly
reduces the collection efficiency. Lowering the flow rate of the AGI-30 and Biosampler
from 12.5 lpm to 4 lpm reduced the observed particle collection efficiency for 0.3
micrometer particles by approximately 80 percent (Hogan, 2005). Similar effects should
be expected for the impinger module on the XMX/2L-MIL. For these reasons, particle
collection efficiency using the modified XMX/2L-MIL is an unlikely cause of the high
performance in comparison to the low volume sampling methods observed in this study.
Particle collection for the DFU-1000 filters were described by Lawrence as being very
efficient for particle collection as low as 0.1 micron in size; however, as described in
chapter two, the conditions under which this reported efficiency was determined are
unknown. Therefore, the effect that the smaller particle size distributions in the low
concentration trials had on the performance of the DFU-1000 cannot be assessed. Other
factors potentially leading to the observed MS2 collection performance of the XMX/2LMIL could include the effect that decreased foaming may have on MS2 activity. The
excessive foaming observed in the AGI-30, when Remel M5 was used as the collection
media, may have significantly lowered the culturable virus recovered in the sample.
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While these observed turbulence effects were significantly lower for the Biosampler,
increased foaming from using Remel M5 without flow reduction may have reduced MS2
activity in the samples collected using the Biosampler as well. Further studies should be
conducted to determine the particle capture efficiency for the modified XMX/2L-MIL,
the AGI-30, and the Biosampler with Remel M5 collection media. Use of quantitative
PCR analysis techniques in future studies could possibly determine the impact, if any,
that increased foaming has on the viability of MS2 in liquid media. Finally, while the
AGI-30 and Biosampler have remarkably better particle collection for small particle
sizes, these smaller particles may contribute less to the total quantity of viable MS2 in the
aerosol. Small particles would dry significantly faster than larger particles, thus exposing
the virus in the particles more to the environmental factors in the chamber. This drying
of liquid viral containing particles was described by Verreault and discussed in chapter
two. If the larger particles present in the test aerosols contained a significantly larger
proportion of viable MS2, this could explain the high performance of the XMX/2L-MIL.

Ambient Conditions and Air Sampling Performance
As discussed in chapter three, ambient conditions including relative humidity and
temperature were kept relatively consistent between trials. The relative humidity levels
of 30 to 32% percent would not be expected to significantly impact the activity of the
aerosolized MS2. This was deomonstrated in studies conducted by Dubovi et al.,
showing that MS2 collection using an AGI-30 was not affected by variations in relative
humidity when the MS2 was suspended in a tryptone broth. The Luria broth used for the
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MS2 aerosol solution in this study contains tryptone in similar amounts to the broth used
by Dubovi. The Dubovi study suggests that changes in relative humidity would not be
expected to significantly impact the collection of our MS2 test aerosol using liquid
collection methodologies. Similar suggestions about the effect of relative humidity on
the collection of MS2 aerosol using the DFU-1000 cannot be made, however. Further
studies should determine if significant changes in relative humidity can effect the
collection of MS2 viral aerosol by either the DFU-1000, XMX/2L-MIL or any other
system under consideration by the Air Force.

Surrogate Virus Use and Sampler Performance
As discussed in chapter two, the use of surrogate virus in aerosol studies cannot be used
to precisely predict the behavior of aerosolized viruses capable of human pathogenesis.
This study, therefore, can only be accurately used to predict the effectiveness of the
collection of MS2 aerosol in a controlled environment. Further studies should compare
collection of other aerosolized viral surrogates and, if possible, live viral agents.

Media Selection and Sampler Performance
As demonstrated by Hermann and discussed in chapter two, collection media for liquid
impinger sampling systems can have a significant influence on overall collection
performance. The results from this study showed that the Remel M5 media used in an
XMX/2L-MIL with impinger flow reduction was very capable at collecting aerosolized
MS2. While a statistically significant difference in MS2 collection between the modified
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XMX/2L-MIL apparatus used in the study and the fielded XMX/2L-MIL configuration
was shown, there are several limitations to this comparison. First, the significance of the
individual modifications within the systems cannot be assessed. Either the reduction in
flow rate to the liquid impinger or the use of Remel M5 media instead of PBS solution
could have been responsible for the increased MS2 collection. Second, the previous
work conducted by Dycor evaluated the collection of MS2 by the XMX/2L-MIL over a
very narrow ACPLA range. The results from this study were obtained over a wide range
of ACPLA in the chamber. Although results were standardized by the ACPLA present,
some difference may be attributable to the variation in ACPLA between the two studies,
such as the difference in particle size distribution discussed previously. Future studies
should assess the performance of collection media through independent, simultaneous,
and side by side evaluations.

DFU-1000 Performance
The two most likely causes of the relatively low MS2 collection by the DFU-1000 at low
to moderate ACPLA levels are problems with filter extraction and desiccation, or drying
of the MS2 during collection. While desiccation of the collected MS2 may significantly
contribute to a reduction in MS2 viability, this would be expected for both high ACPLA
trials and low ACPLA trials. The only difference between collection of MS2 during high
and low ACPLA trials is the amount of collected MS2 on the filter. The presence of
additional MS2 on the filter would not be expected to preserve the viability of the MS2
from the desiccation caused by the rapid flow of air over the filter. Therefore, filter
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extraction is left as the most likely contributor to significantly reduced DFU-1000
performance at lower ACPLA levels. As discussed in chapter 2, relative recovery of
MS2 from a filter significantly increases when large amounts of MS2 are seeded on the
filter as compared with more moderate amounts.

Decontamination
The field use of 10 percent sodium hypochlorite bleach was shown to have similar
effectiveness for the decontamination of the XMX/2L-MIL and the DFU-1000. This
comparison is applicable for both surface decontamination and for reduction in residual
contamination between air samples. As expected, decontamination of viral agents was
shown to be more effective than the decontamination of bacterial agents conducted by
LaRoche. This observation also confirms previous studies demonstrating the greater
susceptibility of viral agents to decontamination than spore-forming bacterial agents. The
results of this study demonstrate that both the XMX/2L-MIL and DFU-1000 can be used
to obtain multiple samples for JBAIDS-PCR analysis in response to a viral agent.
Further enhancements to the bleach solution, such as the reduction of the pH as suggested
by LaRoche, are not necessary to properly decontaminate the equipment after exposure to
viral agents. Furthermore, while only a single viral surrogate was used to compare the
decontamination characteristics of the equipment, non-enveloped viruses are more
resistant to decontamination than enveloped viruses. It would be expected that the
decontamination characteristics for other viral agents on both the XMX/2L-MIL and the
DFU-1000 would be similar to or better than those observed in this study.
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Recommendations
Laboratory Evaluation of Air Sampling Equipment
Further acquisition of commercially produced biological detection equipment should be
evaluated independently for all biological agents of interest. This study shows that a
reasonable evaluation of air sampling equipment can be performed using a limited
number of trials in a laboratory environment. Additionally, acquisition decisions could
be aided by the implementation of the limited comparison evaluation conducted in this
study.

Field Use of Existing High Volume Air Sampling Equipment Inventory
Laboratory evaluation of high volume air sampling equipment demonstrated the
effectiveness of the equipment in the collection of aerosolized MS2. This shows that in
the presence of a sufficient aerosol concentration, both the DFU-1000 and XMX/2L-MIL
are capable of recovering viral samples for both viable and non-viable analysis.
Therefore, both the XMX/2L-MIL and DFU-1000 should continue to be used for field
detection of viral agent in air samples. This study indicates, however, that the XMX/2LMIL should be used, in preference to the DFU-1000, for field uses where relative viable
quantification of a viral agent is desired. Since an effective concentration during the
release of a viral agent would likely be much lower than the concentrations studied in this
comparison, the XMX/2L-MIL would probably be the best choice to ensure viable
collection. Furthermore, if airborne virus concentrations were lower than those used in
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this study, the XMX/2L-MIL would likely be the best choice for PCR detection as well.

Field use of Hypochlorite Decontamination
Decontamination using immersion in 10 percent hypochlorite bleach solution is
recommended for both the XMX/2L-MIL and DFU-1000. Alterations to the bleach
solution, such as the adjustment of pH, should not be necessary to adequately
decontaminate either the XMX/2L-MIL or the DFU-1000 in response to an aerosolized
viral agent.

Future Research Opportunities
Evaluation of Future Air Force Air Sampling Equipment Acquisitions
The Air Force is in the process of considering further additions to the inventory of air
sampling equipment for biological agents. One system under consideration is the
Biocapture 650 manufactured by ICX Technologies: Albuquerque, NM. Civil
Engineering Emergency Management has already purchased this system to enhance
response capability. Collection performance characteristics for agents of interest have
not been compared with the existing inventory. Future studies similar to the work
presented here could be conducted to evaluate the capabilities and limitations provided by
this equipment and to determine if the Biocapture 650 is a reliable substitute for the
existing systems. Furthermore, future equipment under consideration for purchase
should be comparatively evaluated with existing inventory to verify the effectiveness of
new procurements prior to their use as a replacement for existing systems.
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Limit of Detection for XMX/2L-MIL and DFU-1000
The results of this current study were unable to determine a limit of detection for MS2
sampling using the DFU-1000 and the XMX/2L-MIL. Therefore, the possibility still
exists for a high false negative rate on both instruments. Further studies comparing the
DFU-1000, XMX/2L-MIL and future Air Force system acquisitions at minimally
achievable aerosol concentrations should be completed.

Evaluation and Optimization of Collection Media
The importance of sample media selection was shown in this study and by previous
studies conducted by Hermann. More definitive studies should be conducted to evaluate
the application of Remel M5 as a collection media for both low and high volume viral
aerosol collection. Furthermore, optimization of sample media should be considered for
future research. The Air Force operates in a variety of different environments and
locations and sample media should be selected and optimized to meet the needs of the
varied environmental conditions.

Performance Evaluation for Other Agents and Surrogate Agents
One major limitation of this study is that a single surrogate agent, MS2, was used for the
evaluation. The use of MS2, an non-enveloped RNA bacteriophage, was a reasonable
choice for the initial comparison of air sampling equipment since un-enveloped viruses
have more resistance to environmental conditions and decontamination. Some viral
agents of interest, however, such as Variola and Marburg, are enveloped viruses and may
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not exhibit similar collection characteristics. Further research should be conducted using
multiple viral surrogates to evaluate the applicability and performance of the air sampling
equipment.

Conclusions
Comparison of Air Sampling Equipment Effectiveness
This study evaluated and compared numerous characteristics relevant to the field
application of high volume air sampling equipment in response to a biological agent. The
XMX/2L-MIL modified apparatus used in this study appears to have the most promising
capability in terms of collection of aerosolized MS2. This was shown for all ranges of
ACPLA used in this study. While the XMX/2L-MIL was shown to be more effective
than the DFU-1000 in the collection of aerosolized MS2, this study did not provide an
evaluation of the effectiveness of the XMX/2L-MIL at very low levels of airborne agent
concentration. It cannot be inferred from this study that a non-detection result obtained
from an air sample collected using the XMX/2L-MIL could be used to definitively
determine the absence of airborne virus following an aerosol release. A key question
remains for biological air sampling equipment: What does a result of non-detection really
mean? PCR detection was successful on samples collected by the DFU-1000 and
XMX/2L-MIL for all evaluated concentrations of MS2 in this study; however, lower
concentrations may not produce reliable detection by the PCR. Furthermore, this study
identifies many factors that should be considered throughout the selection and evaluation
process of biological sampling equipment including selection of surrogate agent, ambient
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testing conditions, physical aerosol characteristics, equipment alterations, and
decontamination characteristics. Each of these characteristics should be considered
independently in order to fully evaluate any air sampling system. Finally, minimum
airborne concentrations of viral agent necessary to obtain quantitative measurements
from the XMX/2L-MIL cannot be assessed from the results in this project since very low
levels were not obtained during any of the sample trials.

Comparison of Decontamination Characteristics
This study demonstrates that decontamination of air sampling equipment by immersion in
hypochlorite bleach solution is effective for both the XMX/2L-MIL and the DFU-1000.
The results of this study indicate that both the XMX/2L-MIL and DFU-1000 can be
properly decontaminated using techniques and materials available in field conditions and
effectively reused for additional sampling during a response. These findings should
provide greater confidence to responding personnel in the validity of multiple sample
results taken using a limited number of collection systems. The high relative
performance of hypochlorite decontamination for the XMX/2L-MIL and DFU-1000 does
not imply that decontamination by hypochlorite should be assumed for all equipment.
Decontamination should continue to be evaluated as a portion of equipment selection and
use by the Air Force.
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Final Considerations
Biological agents continue to be a key vulnerability in the field response and detection of
weapons of mass destruction. Virtually all detection equipment for chemical, nuclear,
and radiological response has an established limit of detection and a reasonable ability to
quantify the hazard level for exposed personnel. The same cannot be said for the
equipment used in a biological response. At the same time, biological agents would often
be the lowest cost choice for a terrorist organization or rogue state intending to use
unconventional weapons. This study contributes to the knowledge necessary to
effectively conduct sampling for a viral agent. Although limited to a single class of
biological agent and also limited to the equipment currently used by the Air Force, the
author hopes that this study will guide the equipment selection for response personnel
who may face a biological agent head on. Further work is necessary to increase the
knowledge and confidence level associated with the use of this equipment.
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Appendix 1: Trial Matrix and Schedule

Date
27-Jul

Trial Identification
Background 01
Background 02
Trial Run 03
Background 04
Background 05
Trial Run 06
Trial Run 07

28-Jul

Background 08
Trial Run 09
Trial Run 10
Background 11
Background 12

29-Jul

Trial Run 13
Trial Run 14
Trial Run 15
Background 16
Background 17
Trial Run 18

30-Jul

Trial Run 19
Background 20
Trial Run 21
Trial Run 22
Background 23
Background 24
Trial Run 25

31-Jul

Trial Run 26
Background 27
Trial Run 28
Trial Run 29

Description
XMX Surface Swab
Chamber Background Air Sample
MS 2 High ACPLA Air Sample and
Post MS2 Exposure Swab
XMX Surface Swab
Chamber Background Air Sample
MS 2 High ACPLA Air Sample
Post MS2 Exposure Surface Swab
Post Decontamination Surface Swab
and Chamber Background Air
MS 2 High ACPLA Air Sample and
Post MS2 Exposure Swab
Post Decontamination Surface Swab
XMX Surface Swab
Chamber Background Air Sample
MS 2 High ACPLA Air Sample and
Post MS2 Exposure Swab
Post Decontamination Surface Swab
15 Minute Air Purge
XMX Surface Swab
Chamber Background Air Sample
MS 2 High ACPLA Air Sample and
Post MS2 Exposure Swab
Post Decontamination Surface Swab
Chamber Background Air Sample
MS 2 High ACPLA Air Sample and
Post MS2 Exposure Swab
Post Decontamination Surface Swab
XMX Surface Swab
Chamber Background Air Sample
MS 2 High ACPLA Air Sample and
Post MS2 Exposure Swab
Post Decontamination Surface Swab
Chamber Background Air Sample
MS 2 High ACPLA Air Sample and
Post MS2 Exposure Swab
Post Decontamination Surface Swab

Air Sampling Equipment Used
3 XMX
3 XMX
3 XMX
2 XMX
2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
2 XMX, 1 DFU
2 XMX, 1 DFU
2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
2 XMX, 1 DFU
3 XMX
3 XMX
3 XMX
3 XMX
3 XMX
2 XMX
2 XMX, 1 DFU
2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
2 XMX, 1 DFU
2 XMX, 1 DFU
2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
2 XMX, 1 DFU
2 XMX
2 XMX, 1 DFU
2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
2 XMX, 1 DFU
2 XMX, 1 DFU
2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler

Table 20: Sample Matrix and Schedule
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2 XMX, 1 DFU

Appendix 2: Raw Data for Sample Analysis

Table 21: Calculation of ACPLA by Trial
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Count a
1
301
301
1
301
216

AGI-30
Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
0
0
5
0
2.5
301
0
1505
1505
1505
301
1
15050
15050
15050
3
0
5
15
10
301
0
1505
1505
1505
240
1
10800
12000
11400

Trial
Bkg5 (CT)
TR06 (CT)a
TR06 (CT)a
TR06 (CT)a
TR06 (CT)
TR06 (CT)
TR06 (S)
TR07 (S)
Bkg8 (CT)
TR09 (CT)a
TR09 (CT)a
TR09 (CT)a
TR09 (CT)
TR09 (CT)
TR09 (S)a
TR10 (S)

Count a
3
301
301
301
152
3
301
3
2
301
301
301
85
6
301
2

DFU-1000
Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
6
0
15
30
22.5
301
0
1505
1505
1505
301
1
15050
15050
15050
301
2
150500
150500
150500
174
3
760000
870000
815000
19
4
150000
950000
550000
301
0
1505
1505
1505
2
0
15
10
12.5
3
0
10
15
12.5
301
0
1505
1505
1505
301
1
15050
15050
15050
301
2
150500
150500
150500
87
3
425000
435000
430000
16
4
300000
800000
550000
301
0
1505
1505
1505
3
0
10
15
12.5

Trial
Bkg5 (CT)
TR06 (CT)a
TR06 (CT)
Bkg8 (CT)
TR09 (CT)a
TR09 (CT)

Count a
2
301
203
0
301
130

Biosampler
Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
2
0
10
10
10
301
0
1505
1505
1505
223
1
10150
11150
10650
1
0
0
5
2.5
301
0
1505
1505
1505
93
1
6500
4650
5575

Trial
Bkg5 (CT)
TR06 (CT)a
TR06 (CT)a
Bkg8 (CT)
TR09 (CT)a
TR09 (CT)
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Trial
Bkg4 (S)
Bkg5 (CT)
TR06 (CT)a
TR06 (CT)
TR06 (S)
TR06 (S)
TR07 (S)
Bkg8 (CT)
TR09 (CT)
TR09 (CT)
TR09 (S)
TR09 (S)

Count a
4
4
301
77
56
9
2
2
301
49
38
3

XMX - Unit 2
Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
6
0
20
30
25
3
0
20
15
17.5
301
3
1505000 1505000
1505000
54
4
3850000 2700000
3275000
62
2
28000
31000
29500
9
3
45000
45000
45000
2
0
10
10
10
3
0
10
15
12.5
286
3
1505000 1430000
1467500
56
4
2450000 2800000
2625000
45
2
19000
22500
20750
6
3
15000
30000
22500

Trial
Bkg4 (S)
Bkg5 (CT)
TR06 (CT)a
TR06 (CT)
TR06 (S)b
TR07 (S)
Bkg8 (CT)
TR09 (CT)
TR09 (CT)
TR09 (S)b

Count a
1
0
301
53
95
1
12
275
22
186

XMX - Unit 3
Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
0
0
5
0
2.5
2
0
0
10
5
301
3
1505000 1505000
1505000
33
4
2650000 1650000
2150000
66
2
47500
33000
40250
2
0
5
10
7.5
6
0
60
30
45
222
3
1375000 1110000
1242500
21
4
1100000 1050000
1075000
194
2
93000
97000
95000

Trial
Count a
Bkg16 (S)
1
Sample1 (CT)
1
Sample2 (CT)
3
Sample3 (CT)
6
Sample4 (CT)
8

XMX - Unit 4
Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
0
0
5
0
2.5
13
0
5
65
35
6
0
15
30
22.5
7
0
30
35
32.5
6
0
40
30
35

a

Sample Plaques were "Too Numerous to Count". 301 was Used as a Representative Value

b

Sample was "Replated" 24 hours after Collection due to a Mislabeling of Original Sample Plates
S: Denotes Surface Swab Sample
CT: Denotes Air Sample from "Collection Tube"

Table 22: Plate Counts for High ACPLA Trials
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Trial
TR18 (CT)
TR21 (CT)

Count a
34
111

Count b
43
114

AGI-30
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
1
1700
2150
1925
1
5550
5700
5625

Trial
Bkg17 (CT)
TR18 (CT)
Bkg20 (CT)
TR21 (CT)
TR21 (S)
TR22 (S)

Count a
2
119
0
130
162
1

Count b
1
117
1
111
184
0

DFU-1000
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
0
10
5
7.5
3
595000
585000
590000
0
0
5
2.5
2
65000
55500
60250
0
810
920
865
0
5
0
2.5

Trial
TR18 (CT)
TR21 (CT)

Count a
27
49

Count b
22
51

Biosampler
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
1
1350
1100
1225
1
2450
2550
2500

Trial
Bkg16 (S)
Bkg17 (CT)
TR18 (CT)
TR18 (S)
TR19 (S)
Bkg20 (CT)
TR21 (CT)
TR21 (S)
TR22 (S)

Count a
6
0
76
104
3
1
144
60
5

Count b
5
0
80
64
2
0
150
52
1

XMX - Unit 2
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
0
30
25
27.5
0
0
0
0
3
380000
400000
390000
1
5200
3200
4200
0
15
10
12.5
0
5
0
2.5
3
720000
750000
735000
1
3000
2600
2800
0
25
5
15

Trial
Bkg16 (S)
Bkg17 (CT)
TR18 (CT)
TR18 (S)
TR19 (S)
Bkg20 (CT)
TR21 (CT)
TR21 (S)
TR22 (S)

Count a
3
0
87
47
0
0
168
76
2

Count b
3
0
118
65
2
2
177
101
1

XMX - Unit 3
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
0
15
15
15
0
0
0
0
3
435000
590000
512500
1
2350
3250
2800
0
0
10
5
0
0
10
5
3
840000
885000
862500
1
3800
5050
4425
0
10
5
7.5

Trial
Count a
Bkg16 (S)
6
Sample1 (CT)
1
Sample2 (CT)
15
Sample3 (CT)
3
Sample4 (CT)
50

XMX - Unit 4 Work Area Samples
Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
5
0
30
25
27.5
4
0
5
20
12.5
13
0
75
65
70
5
0
15
25
20
36
0
250
180
215

S: Denotes Surface Swab Sample

CT: Denotes Air Sample from "Collection Tube"

Table 23: Plate Counts for Moderate ACPLA Trials
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Trial
TR25 (CT)
TR28 (CT)

Count a
37
41

Count b
51
53

AGI-30
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
0
185
255
220
0
205
265
235

Trial
Bkg24 (CT)
TR25 (CT)
TR25 (S)
Bkg27 (CT)
TR28 (CT)
TR28 (S)
TR29 (S)

Count a
1
16
24
0
21
70
2

Count b
1
40
37
0
32
108
2

DFU
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
0
5
5
5
2
8000
20000
14000
0
120
185
152.5
0
0
0
0
2
10500
16000
13250
0
350
540
445
0
10
10
10

Trial
TR25 (CT)
TR28 (CT)

Count a
24
28

Count b
23
22

Biosampler
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
0
120
115
117.5
0
140
110
125

Trial
Bkg23 (S)
Bkg24 (CT)
TR25 (CT)
TR25 (S)
TR26 (S)
Bkg27 (CT)
TR28 (CT)
TR28 (S)
TR29 (S)

Count a
0
0
55
10
1
32
81
13
1

Count b
0
0
55
12
1
40
127
13
0

XMX - Unit 2
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
0
0
0
0
0
0
0
0
3
275000
275000
275000
1
500
600
550
0
5
5
5
0
160
200
180
2
40500
63500
52000
1
650
650
650
0
5
0
2.5

Trial
Bkg23 (S)
Bkg24 (CT)
TR25 (CT)
TR25 (S)
TR26 (S)
Bkg27 (CT)
TR28 (CT)
TR28 (S)
TR29 (S)

Count a
4
0
99
9
1
9
68
10
1

Count b
1
1
100
15
0
24
53
14
0

XMX - Unit 3
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
0
20
5
12.5
0
0
5
2.5
3
495000
500000
497500
1
450
750
600
0
5
0
2.5
0
45
120
82.5
2
34000
26500
30250
1
500
700
600
0
5
0
2.5

Trial
Count a
Bkg23 (S)
0
Sample1 (CT)
6
Sample2 (CT)
6
Sample3 (CT)
4
Sample4 (CT)
3

Count b
1
3
8
2
3

XMX - Unit 4
Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
0
0
5
2.5
0
30
15
22.5
0
30
40
35
0
20
10
15
0
15
15
15

S: Denotes Surface Swab Sample

CT: Denotes Air Sample From "Collection Tube"

Table 24: Plate Counts for Low ACPLA Trials
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Cap #

Sample

CP

101

101 -Bkg4 U2 Swabs

45.00

101

Repl. Of 101

45.00

102

102 -Bkg4 U3 Swabs

45.00

102

Repl. Of 102

45.00

103

103 -Bkg4 U4 Swabs

45.00

103

Repl. Of 103

45.00

104

104 -Bkg5 U2 CT

45.00

104

Repl. Of 104

45.00

105

105 -Bkg5 U3 CT

45.00

105

Repl. Of 105

45.00

106

106 -TRG U2 CT

29.71

106

Repl. Of 106

29.74

107

107 -TR06 U2 Swabs

34.95

107

Repl. Of 107

35.82

108

108 -TR06 U3 CT

24.58

108

Repl. Of 108

24.58

109

109 -TRG U3 Swabs

32.76

109

Repl. Of 109

32.84

110

110 -Predecon TR06 DFU

37.86

110

Repl. Of 110

45.00

111

111 -Bkg 07 Post decon DFU

45.00

111

Repl. Of 111

45.00

112

112 -Post decon swabs - XMX U2

45.00

112

Repl. Of 112

45.00

113

113 -Post decon 743 Swabs

45.00

113

Repl. Of 113

45.00

114

114 -Bkg 8 U2 CT

45.00

114

Repl. Of 114

45.00

115

115 -Bkg 8 U3 CT

45.00

115

Repl. Of 115

45.00

116

116 - Pre decon DFU TR 09 PM

35.77

116

Repl. Of 116

34.65

117

117 -Post TR9 Bkg DFU Post clean pm

45.00

117

Repl. Of 117

45.00

118

118 -TR9 U2 CT

45.00

118

Repl. Of 118

45.00

119

119 -TR9 U2 Swabs

31.65

119

Repl. Of 119

31.55

120

120 -TR9 U3 CT

24.93

120

Repl. Of 120

25.05

121

121 -TR9 U3 swabs

30.88

121

Repl. Of 121

30.79

122

122 -Post decon 10 U2 Swabs

45.00

122

Repl. Of 122

45.00

123

123 -Post decon 10 U3 Swabs

45.00

123

Repl. Of 123

45.00

124

124 -AGI Bkg 05

45.00

124

Repl. Of 124

45.00

125

125 -AGI TR 06

32.11

125

Repl. Of 125

32.06
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126

126 -AGI Bkg 08

45.00

126

Repl. Of 126

45.00

127

127 -AGI TR09

33.08

127

Repl. Of 127

33.27

128

128 -Biosampler TR06

128

Repl. Of 128

32.59

129

129 -Biosampler Bkg 05

45.00

129

Repl. Of 129

45.00

130

130 -Biosampler BKg08

45.00

130

Repl. Of 130

45.00

131

131 -Biosampler TR09

32.48

131

Repl. Of 131

32.82

132

132 -DFU Chamber Blank Bkg5

45.00

132

Repl. Of 132

45.00

133

133 -DFU TR6

25.48

133

Repl. Of 133

25.66

134

134 -DFU BKG8

45.00

134

Repl. Of 134

45.00

135

135 -DFU TR09 release

28.61

135

Repl. Of 135

28.64

136

136 -U4 CT1 28July TR 6-10

45.00

136

Repl. Of 136

45.00

137

137 -28july TR6-10 U4 CT2

45.00

137

Repl. Of 137

45.00

138

138 -TR6-10 U4 CT3

45.00

138

Repl. Of 138

45.00

139

139 -28july TR6-10 U4 CT4

45.00

139

Repl. Of 139

45.00

140

140 -BKG 16 U2 Swabs

45.00

140

Repl. Of 140

45.00

141

141 -BKG 16 U3 Swabs

45.00

141

Repl. Of 141

45.00

142

142 -BKG 16 U4 Swabs

45.00

142

Repl. Of 142

45.00

143

143 -BKG 17 U2 CT

45.00

143

Repl. Of 143

45.00

144

144 -BKG 17 U2 CT

45.00

144

Repl. Of 144

45.00

145

145 -TR18 U2 CT

28.52

145

Repl. Of 145

28.62

146

146 -TR18 U2 Swabs

32.88

146

Repl. Of 146

33.67

147

147 -TR18 U3 CT

27.21

147

Repl. Of 147

27.51

148

148 -TR18 U3 Swabs

33.68

148

Repl. Of 148

34.46

149

149 -DFU Bkg 17

45.00

149

Repl. Of 149

45.00

150

150 -DFU TR18

30.46

150

Repl. Of 150

30.31
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32.6

151

151 -AGI BKG17

45.00

151

Repl. Of 151

45.00

152

152 -AG1TR18

152

Repl. Of 152

35.38

153

153 -SKC BKG 17

45.00

153

Repl. Of 153

45.00

154

154 -SKC TR18

35.04

154

Repl. Of 154

35.17

155

155 -PD19 U2 Swabs

45.00

155

Repl. Of 155

45.00

156

156 -PD 19 U3 Swabs

45.00

156

Repl. Of 156

45.00

157

157 -Bkg20 U2 CT

45.00

157

Repl. Of 157

45.00

158

158 -Bkg 20 U3 CT

45.00

158

Repl. Of 158

45.00

159

159 - TR21 U2 CT

28.64

159

Repl. Of 159

160

160 -TR21 U3 CT

29.28

160

Repl. Of 160

29.19

161

161 -TR21 U2 Swabs

34.00

161

Repl. Of 161

34.72

162

162 -TR21 U3 Swabs

33.12

162

Repl. Of 162

33.05

163

163 -TR21 Pre-decon DFU 30July pm

34.91

163

Repl. Of 163

34.76

164

164 -Post decon 27 (22)

45.00

164

Repl. Of 164

45.00

165

165 -PD 2d U2 Swabs

45.00

165

Repl. Of 165

45.00

166

166 -PD22 U3 Swabs

45.00

166

Repl. Of 166

45.00

167

167 -PD22 U3 Swabs

45.00

167

Repl. Of 167

45.00

168

168 -BKG 20 SKC

38.14

168

Repl. Of 168

40.00

169

169 -BKG 20 AGI

45.00

169

Repl. Of 169

45.00

170

170 -TR21 AGI

36.18

170

Repl. Of 169

45.00

171

171 -DFU Bkg 20

45.00

171

Repl. Of 171

45.00

172

172 -DFU TR21

32.28

172

Repl. Of 172

32.02

173

173 -U4 #1 30Jul

45.00

173

Repl. Of 173

45.00

174

174 -U4 #2 30Jul

45.00

174

Repl. Of 174

45.00

175

175 -U4 #3 30 Jul

45.00

175

Repl. Of 175

45.00

35.8

28.5
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176

176 -U4 #4 30Jul

40.00

176

Repl. Of 176

45.00

180

180 -Bkg 23 U2 Swabs

45.00

180

Repl. Of 180

45.00

181

181 -Bkg 23 U3 Swabs

45.00

181

Repl. Of 181

45.00

182

182 -Bkg 23 U4 Swabs

45.00

182

Repl. Of 182

45.00

183

183 - TR25 U2 CT

36.37

183

Repl. Of 183

34.44

184

184 - TR25 U3 CT

34.80

184

Repl. Of 184

34.82

185

185 -TR25 U2 Swabs

45.00

185

Repl. Of 185

45.00

186

186 -TR25 U3 Swabs

36.65

186

Repl. Of 186

37.10

187

187 -PD26 U3 Swabs

45.00

187

Repl. Of 187

45.00

188

188 - PD26 U2 Swabs

45.00

188

Repl. Of 188

45.00

189

189 - TR 25 SKC

45.00

189

Repl. Of 189

45.00

191

191 -DFU Post Decon TR25

45.00

191

Repl. Of 191

45.00

192

192 -DFU Pre Decon TR25

37.24

192

Repl. Of 192

45.00

193

193 -DFU

45.00

193

Repl. Of 193

45.00

194

194 -DFU TR25

33.56

194

Repl. Of 194

34.82

195

195 -DFU Bkg 24

45.00

195

Repl. Of 195

45.00

196

196 -BKG 27 U2 CT

36.16

196

Repl. Of 196

45.00

197

197 -BKG 27 U3 CT

45.00

197

Repl. Of 197

45.00

198

198 -TR28 U2 CT

45.00

198

Repl. Of 198

37.45

199

199 -TR28 U3 CT

199

Repl. Of 199

30.98

200

200 -TR28 U2 Swabs

45.00

200

Repl. Of 200

45.00

201

201 -TR28 U3 Swabs

36.39

201

Repl. Of 201

45.00

202

202 -PO 29 U2 Swabs

45.00

202

Repl. Of 202

45.00

203

203 -PO29 U3 Swabs

45.00

203

Repl. Of 203

45.00

204

204 - AGI TR28

204

Repl. Of 204

37.00

205

205 -SKC TR28

45.00

205

Repl. Of 205

45.00

31.2

36.8
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206

206 -DFU TR28

206

Repl. Of 206

35.89

35.8

207

207 -DFU Bkg 27

45.00

207

Repl. Of 207

45.00

208

208 - DFU TR28 swab Pre-Decon

45.00

208

Repl. Of 208

45.00

209

209- DFU TR29 Post-Decon

45.00

209

Repl. Of 209

45.00

210

210 -U4 #4 31July

45.00

210

Repl. Of 210

45.00

211

211 -U4 #3 31July

45.00

211

Repl. Of 211

45.00

Table 25: JBAIDS PCR Analysis of MS2 Samples (From Applied Technology Center)
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Appendix 3: Particle Loading in Chamber
(All Plots are 3 Sample, 18 Second Moving Averages)

Particle Coun (# Particles/Sample)
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Figure 28: Particle Load in Chamber as a Function of Time, Trial 09
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Figure 29: Particle Load in Chamber as a Function of Time, Trial 18
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Figure 30: Particle Load in Chamber as a Function of Time, Trial 21
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Figure 31: Particle Load in Chamber as a Function of Time, Trial 25
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Figure 32: Particle Load in Chamber as a Function of Time, Trial 28
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Appendix 4: Air Sample Comparison Data

TR 06 -- High ACPLA (Target ACPLA = 100 , Actual ACPLA =93.2)
Sample Run Time (min)
5
Q (L/min)
XMX Unit 2 Flow Rate
672
XMX Unit 3 Flow Rate
672
DFU Flow Rate
843
Biosampler Flow Rate
12.5
AGI-30 Flow Rate
12.75
Temp (Deg C)
26
Temp (Deg K)
299
Pressure (kPa)
93.83
Relative Humidity (%)
34.3
Instrument
XMX Unit 2
XMX Unit 3
DFU
SKC
a
AGI-30

Viral Media Conc. (PFU/ml) Media Vol. Initial Media Vol. Final
2150000
5
5
3275000
5
5
815000
15
15
10650
20
18.5
15050
20
12.5

Air Conc. (PFU/Liter of Air)
3199
4874
2900
3152
2951

TR 09 -- High ACPLA (Target ACPLA = 100, Actual ACPLA = 74.4 )
Sample Run Time (min)
5
Q (L/min)
XMX Unit 2 Flow Rate
672
XMX Unit 3 Flow Rate
672
DFU Flow Rate
843
Biosampler Flow Rate
12.5
AGI-30 Flow Rate
12.75
Temp (Deg C)
25.7
Temp (Deg K)
298.7
Pressure (kPa)
93.77
Relative Humidity (%)
33.6
Instrument
XMX Unit 2
XMX Unit 3
DFU
SKC
AGI-30

Viral Media Conc (PFU/ml) Media Vol. Initial Media Vol. Final
2625000
5
5
1075000
5
5
430000
15
15
5575
20
19
11400
20
11

a

Air Conc. (PFU/Liter of Air)
3906
1600
1530
1695
1967

Plate was "Too Numerous to Count". Minimum Plate Value of 301 PFU used for Media Conc. and Air Conc.
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TR 18 -- Moderate ACPLA (Target ACPLA= 10, Actual ACPLA = 13.9)
Sample Run Time (min)
XMX Unit 2 Flow Rate
XMX Unit 3 Flow Rate
DFU Flow Rate
Biosampler Flow Rate
AGI-30 Flow Rate
Temp (Deg C)
Temp (Deg K)
Pressure (kPa)
Relative Humidity (%)
ACPLA
Instrument
XMX Unit 2
XMX Unit 3
DFUb
SKC
AGI-30

5
Q (L/min)
672
672
843
12.5
12.75
26.6
299.6
92.93
30.8
13.9
Viral Media Conc (PFU/ml) Media Vol. Initial Media Vol. Final
390000
5
5
512500
5
5
590000
15
15
1225
20
19
1925
20
12.5

Air Conc. (PFU/Liter of Air)
580
763
2100
372
377

TR 21 -- Moderate ACPLA (Target ACPLA = 10, Actual ACPLA = 21)
Sample Run Time (min)
XMX Unit 2 Flow Rate
XMX Unit 3 Flow Rate
DFU Flow Rate
Biosampler Flow Rate
AGI-30 Flow Rate
Temp (Deg C)
Temp (Deg K)
Pressure (kPa)
Relative Humidity (%)
ACPLA
Instrument
XMX Unit 2
XMX Unit 3
DFU
SKC
AGI-30

5
Q (L/min)
672
672
843
12.5
12.75
26
299
92.92
30.5
21
Viral Media Conc. (PFU/ml) Media Vol. Initial Media Vol. Final
735000
5
5
862500
5
5
60250
15
15
2500
20
19.5
5625
20
12

b

Air Conc. (PFU/Liter of Air)
1094
1283
214
780
1059

Plate Sample Dilution was Recorded One Order of Magnitude too Low. Results Excluded from Analysis
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TR 25-- Low ACPLA (Target = 1 ACPLA, Actual ACPLA = 9.3)
Sample Run Time (min)
XMX Unit 2 Flow Rate
XMX Unit 3 Flow Rate
DFU Flow Rate
Biosampler Flow Rate
AGI-30 Flow Rate
Temp (Deg C)
Temp (Deg K)
Pressure (kPa)
Relative Humidity (%)
ACPLA
Instrument
XMX Unit 2
XMX Unit 3
DFU
c
SKC
c
AGI-30

5
Q (L/min)
672
672
843
12.5
12.75
25.5
298.5
93.45
34.3
9.3
Viral Media Conc. (PFU/ml)Media Volume InitiMedia Volume Final Air Conc. (PFU/Liter of Air)
275000
5
5
409
497500
5
5
740
14000
15
15
50
118
20
19
36
220

20

14

48

TR 28 -- Low ACPLA (Target ACPLA = 1, Actual ACPLA = 18.4 )
Sample Run Time (min)
XMX Unit 2 Flow Rate
XMX Unit 3 Flow Rate
DFU Flow Rate
Biosampler Flow Rate
AGI-30 Flow Rate
Temp (Deg C)
Temp (Deg K)
Pressure (kPa)
Relative Humidity (%)
ACPLA

18.4
Instrument
XMX Unit 2c
XMX Unit 3
DFU
SKCc
AGI-30

c

5
Q (L/min)
672
672
843
12.5
12.75
26
299
93.3
37.6

c

c

Viral Media Conc. (PFU/ml) Media Vol. Initial Media Vol. Final
52000
30250
13250
125
235

5
5
15
20
20

Air Conc. (PFU/Liter of Air)

5
5
15
18.5
13

Plate Sample Dilution was Recorded One Order of Magnitude too High. Results Excluded from Analysis
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77
45
47
37
48

Appendix 5: Decontamination Comparison Trial Data

Decontamination Trial 1: Background 5 (Pre-Exposure Background)
Time (min)
5

XMX 2
XMX 3
DFU

Q (L/min)
672
672
843

Background 05

ACPLA =

0

Instrument
XMX 2
XMX 3
DFU

Media Conc (PFU/ml)
17.5
5
22.5

Air Conc. (PFU/Liter of Air)
0.026
0.007
0.080

Instrument
XMX 2
XMX 3
DFU

PCR A Result
Negative
Negative
Negative

Cycles A
45
45
45

PCR B Result
Negative
Negative
Negative

Cycles B
45
45
45

PCR B Result
Positive
Positive
Positive

Cycles B
29.74
24.58
25.66

Decontamination Trial 1: Trial 06 (Exposure)
Time (min)
5

XMX 2
XMX 3
DFU

Trial Run 06

Q (L/min)
672
672
843

ACPLA =

93.2

Instrument
XMX 2
XMX 3
DFU

Media Conc. (PFU/ml)
2150000
3275000
815000

Air Conc. (PFU/Liter of Air)
3199
4874
2900

Instrument
XMX 2
XMX 3
DFU

PCR A Result
Positive
Positive
Positive

Cycles A
29.71
24.58
25.48
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Decontamination Trial 1: Background 08 (Post Decontamination)
Time (min)
5

XMX 2
XMX 3
DFU

Q (L/min)
672
672
843

Background 08

ACPLA =

Instrument
XMX 2
XMX 3
DFU
Instrument
XMX 2
XMX 3
DFU

0

Media Conc (PFU/ml) Measurement (PFU/Liter of Air)
12.5
0.019
45
0.067
12.5
0.044
PCR A Result
Negative
Negative
Negative

Cycles A
45
45
45

PCR B Result
Negative
Negative
Negative

Cycles B
45
45
45

PCR B Result
Negative
Negative
Negative

Cycles B
45
45
45

% Reduction w/ 10% Bleach
XMX 2
99.999
XMX 3
99.999
DFU
99.998

Decontamination Trial 2: Background 17 (Pre-Exposure Background)
Sample Run Tim
Collector
XMX 2
XMX 3
DFU

5
Q (L/min)
672
672
843

Background 17

ACPLA =

0

Collector
XMX Unit 2
XMX Unit 3
DFU

Media Conc (PFU/ml)
0
0
7.5

Air Conc. (PFU/Liter of Air)
0.000
0.000
0.027

Instrument
XMX Unit 2
XMX Unit 3
DFU

PCR A Result
Negative
Negative
Negative

Cycles A
45
45
45
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Decontamination Trial 2: Trial 18 (Exposure)
Time (min)

5

XMX 2
XMX 3
DFU

Q (L/min)
672
672
843

Trial Run 18

ACPLA =

13.9

Collector
XMX Unit 2
XMX Unit 3
DFUa

Media Conc (PFU/ml)
390000
512500
59000

Air Conc. (PFU/Liter of Air)
580
763
210

Instrument
XMX Unit 2
XMX Unit 3
DFU

PCR A Result
Positive
Positive
Positive

Cycles A
28.52
27.21
30.46

PCR B Result
Positive
Positive
Positive

Cycles B
28.62
27.51
30.31

PCR B Result
Negative
Negative
Negative

Cycles B
45
45
45

Decontamination Trial 2: Background 20 (Post Decontamination)
Time (min)

5

XMX 2
XMX 3
DFU

Q (L/min)
672
672
843

Background 20

ACPLA =

0

Instrument
XMX Unit 2
XMX Unit 3
DFU

Media Conc. (PFU/ml)
2.5
5
2.5

Air Conc. (PFU/Liter of Air)
0.004
0.007
0.009

Instrument
XMX Unit 2
XMX Unit 3
DFU

PCR A Result
Negative
Negative
Negative

Cycles A
45
45
45

% Reduction w/ 10% Bleach
XMX Unit 2
99.999
XMX Unit 3
99.999
DFU
99.996
a

Corrected Data
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Decontamination Trial 3: Background 24 (Pre-Exposure Background)
Time (min)

5

XMX 2
XMX 3
DFU

Q (L/min)
672
672
843

Background 24

ACPLA =

Instrument
XMX Unit 2
XMX Unit 3
DFU
Instrument
XMX 2b
XMX 3b
DFU

0

Media Conc. (PFU/ml) Air Conc.
0
2.5
5
PCR A Result
N/A
N/A
Negative

(PFU/Liter of Air)
0.000
0.004
0.018

Cycles A

45

PCR B Result
N/A
N/A
Negative

Cycles B

PCR B Result
Positive
Positive
Positive

Cycles B
34.44
34.82
34.82

45

b

PCR Results Not Available for this Sample

Decontamination Trial 3: Trial 25 (Exposure)
Time (min)
XMX 2
XMX 3
DFU

Trial Run 25
Instrument
XMX Unit 2
XMX Unit 3
DFU
Instrument
XMX Unit 2
XMX Unit 3
DFU

5
Q (L/min)
672
672
843

ACPLA =

9.3

Media Conc. (PFU/ml) Air Conc. (PFU/Liter of Air)
275000
409
497500
740
14000
50
PCR A Result
Positive
Positive
Positive

Cycles A
36.37
34.8
33.56
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Decontamination Trial 3: Background 27 (Post Decontamination)
Time (min)

5

XMX 2
XMX 3
DFU

Q (L/min)
672
672
843

Background 27

ACPLA =

Instrument
XMX 2
XMX 3
DFU
Instrument
XMX 2
XMX 3
DFU

0

Media Conc. (PFU/ml) Air Conc.
180
82.5
0
PCR A Result
Positive
Negative
Negative

(PFU/Liter of Air)
0.268
0.123
0.000

Cycles A
36.16
45
45

% Reduction w/ 10% Bleach
XMX 2
99.935
XMX 3
99.983
DFU
100
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PCR B Result
Negative
Negative
Negative

Cycles B
45
45
45

Appendix 6: Statistical Analysis

Instrument
AGI
Biosampler
DFU
XMX 2
XMX 3
Overall

N Median
4
29.39
4
30.29
5
10.19
5
43.98
5
54.89
23

H = 13.41

DF = 4

Ave
Rank
11.0
10.0
4.0
16.4
18.0
12.0

Z
-0.32
-0.65
-2.98
1.64
2.24

P = 0.009

* NOTE * One or more small samples

Table 26: Kruskal-Wallis Analysis of Air Sampling Equipment Comparison for MS2

Table 27: Dunn's Multiple Comparison Test of Air Sampling Equipment for MS2

Instrument
DFU
XMX 2
XMX 3
Overall

H = 3.13

N Median
4
99.17
5
99.62
5
99.70
14

Ave
Rank
Z
4.8 -1.56
7.5
0.00
9.7
1.47
7.5

H = 3.11 DF = 2 P = 0.211
DF = 2 P = 0.209 (adjusted for ties)

* NOTE * One or more small samples

Table 28: Kruskal-Wallis Analysis of Surface Decontamination by Instrument
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Instrument
DFU
XMX 2
XMX 3
Overall

H = 2.38

Ave
Median
99.99
99.99
99.99

N
3
3
3
9

Rank
6.7
4.0
4.3
5.0

Z
1.29
-0.77
-0.52

H = 1.69 DF = 2 P = 0.430
DF = 2 P = 0.304 (adjusted for ties)

* NOTE * One or more small samples

Table 29: Kruskal-Wallis Analysis of Contamination Reduction between Air Samples

Ave
Rank
4.4
9.8

Instrument
N Median
XMX Dycor
5
36.51
XMX SAM
10
56.55
Overall
15
H = 4.86

DF = 1

Z
-2.20
2.20
8.0

P = 0.027

Table 30: Kruskal-Wallis Analysis of XMX Dycor Apparatus and XMX SAM Apparatus

Trial Phase
Background
Post Decontamination
Overall

H = 1.23

N
3
3

Median
0.000000000
0.019000000
6

Ave
Rank
2.7
4.3

Z
-1.09
1.09
3.5

H = 1.19 DF = 1 P = 0.275
DF = 1 P = 0.268 (adjusted for ties)

* NOTE * One or more small samples

Table 31: Kruskal-Wallis Analysis of Post-Decon Air Sample vs. Background for XMX 2

Trial Phase
Background
Post Decontamination
Overall

H = 3.14

N
3
3
6

Median
0.004000
0.067000

Ave
Rank
2.2
4.8
3.5

Z
-1.75
1.75

H = 3.05 DF = 1 P = 0.081
DF = 1 P = 0.077 (adjusted for ties)

Table 32: Kruskal-Wallis Analysis of Post-Decon Air Sample vs. Background for XMX 3
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Trial Phase
Background
Post Decontamination
Overall
H = 1.19

N
3
3
6

Median
0.027000
0.009000

DF = 1

Ave
Rank
4.3
2.7
3.5

Z
1.09
-1.09

P = 0.275

* NOTE * One or more small samples

Table 33: Kruskal-Wallis Analysis of Post-Decon Air Sample vs. Background for DFU

Trial
N Median
TR 06
51 1.5987
TR 09
51 1.2987
TR 18
51 0.3969
TR 21
51 0.4500
TR 25
51 0.3969
TR 28
51 0.3806
Overall 306

H = 129.08

Ave
Rank
Z
239.6
7.61
228.4
6.62
111.9 -3.68
123.2 -2.68
102.8 -4.48
115.2 -3.39
153.5

H = 128.38 DF = 5 P = 0.000
DF = 5 P = 0.000 (adjusted for ties)

Table 34: Kruskal-Wallis Analysis of CMD between Trial Runs

Table 35: Dunn's Multiple Comparison Test of CMD's between Trial Runs
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Appendix 7: Air Sampling Results with Excluded Data
XMX 2

XMX 3
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20
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Figure 33: MS2 Air Sample Collection Relative to ACPLA Present in Chamber with Excluded Data
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Appendix 8: Air Sample Concentration with Corrected Data

TR 06 -- High ACPLA (Target ACPLA = 100 , Actual ACPLA =93.2)
Sample Run Time (min)
5
Q (L/min)
XMX Unit 2 Flow Rate
672
XMX Unit 3 Flow Rate
672
DFU Flow Rate
843
Biosampler Flow Rate
12.5
AGI-30 Flow Rate
12.75
Temp (Deg C)
26
Temp (Deg K)
299
Pressure (kPa)
93.83
Relative Humidity (%)
34.3

Instrument
XMX Unit 2
XMX Unit 3
DFU
SKC
a
AGI-30

Viral Media Conc. (PFU/ml) Media Vol. Initial
2150000
5
3275000
5
815000
15
10650
20
15050
20

Media Vol. Final
5
5
15
18.5
12.5

Air Conc. (PFU/Liter of Air)
3199
4874
2900
3152
2951

Media Vol. Final
5
5
15
19
11

Air Conc. (PFU/Liter of Air)
3906
1600
1530
1695
1967

TR 09 -- High ACPLA (Target ACPLA = 100, Actual ACPLA = 74.4 )
Sample Run Time (min)
5
Q (L/min)
XMX Unit 2 Flow Rate
672
XMX Unit 3 Flow Rate
672
DFU Flow Rate
843
Biosampler Flow Rate
12.5
AGI-30 Flow Rate
12.75
Temp (Deg C)
25.7
Temp (Deg K)
298.7
Pressure (kPa)
93.77
Relative Humidity (%)
33.6

Instrument
XMX Unit 2
XMX Unit 3
DFU
SKC
AGI-30

Viral Media Conc (PFU/ml) Media Vol. Initial
2625000
5
1075000
5
430000
15
5575
20
11400
20

a

Corrected
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TR 18 -- Moderate ACPLA (Target ACPLA= 10, Actual ACPLA = 13.9)
Sample Run Time (min)
XMX Unit 2 Flow Rate
XMX Unit 3 Flow Rate
DFU Flow Rate
Biosampler Flow Rate
AGI-30 Flow Rate
Temp (Deg C)
Temp (Deg K)
Pressure (kPa)
Relative Humidity (%)

Instrument
XMX Unit 2
XMX Unit 3
DFUa
SKC
AGI-30

5
Q (L/min)
672
672
843
12.5
12.75
26.6
299.6
92.93
30.8

Viral Media Conc (PFU/ml) Media Vol. Initial
390000
5
512500
5
59000
15
1225
20
1925
20

Media Vol. Final
5
5
15
19
12.5

Air Conc. (PFU/Liter of Air)
580
763
210
372
377

Media Vol. Final
5
5
15
19.5
12

Air Conc. (PFU/Liter of Air)
1094
1283
214
780
1059

TR 21 -- Moderate ACPLA (Target ACPLA = 10, Actual ACPLA = 21)
Sample Run Time (min)
XMX Unit 2 Flow Rate
XMX Unit 3 Flow Rate
DFU Flow Rate
Biosampler Flow Rate
AGI-30 Flow Rate
Temp (Deg C)
Temp (Deg K)
Pressure (kPa)
Relative Humidity (%)

Instrument
XMX Unit 2
XMX Unit 3
DFU
SKC
AGI-30

5
Q (L/min)
672
672
843
12.5
12.75
26
299
92.92
30.5

Viral Media Conc. (PFU/ml) Media Vol. Initial
735000
5
862500
5
60250
15
2500
20
5625
20

a

Corrected
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TR 25-- Low ACPLA (Target = 1 ACPLA, Actual ACPLA = 9.3)
Sample Run Time (min)
XMX Unit 2 Flow Rate
XMX Unit 3 Flow Rate
DFU Flow Rate
Biosampler Flow Rate
AGI-30 Flow Rate
Temp (Deg C)
Temp (Deg K)
Pressure (kPa)
Relative Humidity (%)

Instrument
XMX Unit 2
XMX Unit 3
DFU
SKCa
AGI-30a

5
Q (L/min)
672
672
843
12.5
12.75
25.5
298.5
93.45
34.3

Viral Media Conc. (PFU/ml)Media Volume InitiaMedia Volume Final Air Conc. (PFU/Liter of Air)
275000
5
5
409
497500
5
5
740
14000
15
15
50
1180
20
19
359
2200

20

14

483

TR 28 -- Low ACPLA (Target ACPLA = 1, Actual ACPLA = 18.4 )
Sample Run Time (min)
XMX Unit 2 Flow Rate
XMX Unit 3 Flow Rate
DFU Flow Rate
Biosampler Flow Rate
AGI-30 Flow Rate
Temp (Deg C)
Temp (Deg K)
Pressure (kPa)
Relative Humidity (%)

Instrument
a
XMX Unit 2
a
XMX Unit 3
DFU
SKCa
AGI-30

a

5
Q (L/min)
672
672
843
12.5
12.75
26
299
93.3
37.6

Viral Media Conc. (PFU/ml) Media Vol. Initial

Media Vol. Final

Air Conc. (PFU/Liter of Air)

520000
302500
13250
1250

5
5
15
20

5
5
15
18.5

774
450
47
370

2350

20

13

479

a

Corrected
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Appendix 9: Corrected Air Sampling Data Analysis
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Figure 34: MS2 Air Sample Collection Relative to ACPLA Present in Chamber with Corrected Data

XMX 2
Linear (XMX 2)

XMX 3
Linear (XMX 3)

DFU
Linear (DFU)

5500

4500

DFU Linear Fit Eqn XMX 2 Linear Fit Eqn XMX 3 Linear Fit Eqn
y = 31.463x - 381.97 y = 39.124x + 159.28 y = 39.304x + 110.36
R² = 0.7336
R² = 0.9444
R² = 0.8774

PFU / Liter of Air

3500

2500

1500

500

-500 0

20

40

60

80

100

ACPLA

Figure 35: MS2 Collection by High Volume Air Sampling Equipment with Linear Trendlines
(Corrected Data)
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Instrument
AGI
Biosampler
DFU
XMX 2
XMX 3
Overall

N Median
6
29.39
6
30.29
6
12.65
6
46.91
6
53.59
30

H = 13.36

DF = 4

Ave Rank
Z
16.3
0.26
13.8 -0.52
5.2 -3.21
21.2
1.76
21.0
1.71
15.5
P = 0.010

Table 36: Kruskal-Wallis Analysis of Air Sampling Equipment Comparison for MS2 (Corrected
Data)

Table 37: Dunn's Multiple Comparison Test of Air Sampling Equipment for MS2 (Corrected Data)
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